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Abstract 
This thesis reports work in the area of modified nucleosides for potential use as 
molecular probes in nucleic acid chemistry. These heterocyclic base surrogates that are 
capable of canonical base pairing have use in the study of nucleic acid conformation, as 
reporters of the state of hybridization.[1]    
The synthesis of a 5-phenylpyrrolocytidine was attempted in order to compare its 
properties with its 6-substituted pyrrolocytidine counterpart. Unfortunately, the 5-substituted 
pyrrolocytidine was not achieved. 
The synthesis of five nucleosides based on the pyrrolocytidine scaffold was reported. 
Their synthesis was achieved through the tandem Sonogashira/annulations reaction between 
5-iodocytidine derivatives and terminal alkynes to yield the bicyclic nucleoside 
pyrrolocytidine.  
Photophysical studies were performed to determine possible FRET pairs to be used as 
molecular beacons and Stern-Volmer plots were used to determine how effective each 
quencher was at reducing the fluorescence intensity of the fluorophores. The molar 
absorptivity of a 6-DABCYL mimic pyrrolocytidine was determined and compared with the 
universal quencher DABCYL.      
Keywords 
DNA, Organic Synthesis, Modified Nucleobases, Deoxycytidine, Pyrrolocytidine, 5-
iododeoxycytidine, Quencher, Fluorophore, Stern-Volmer plot. 
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Chapter 1  
1 Introduction to nucleic acid chemistry 
Dr. Friedrich Miescher, a Swiss scientist, was the first to isolate a novel non- 
protein substance from the nuclei of white blood cells in 1869 which he called 
“nuclein.”[2] His original findings were made using puss samples obtained from bandages 
that were discarded from local hospitals. Over the next 70 years many scientists made 
very important discoveries regarding nuclein, including: a protein free extract of nuclein 
prepared by Richard Altmann in 1889, which he called nucleic acid; Jacobs and Levene 
worked with nucleotides, and identified the phosphate, sugar and nucleobase 
components.[2]  
 In 1942 Oswald T. Avery, Colin M. MacLeod and Maclyn McCarty indentified 
Miescher’s original discovery, which we now know as DNA, to be the molecule of 
genetic inheritance.[3] The chemical structure was later elucidated in 1953 by James D. 
Watson and Francis H. C. Crick. These key findings have since changed how we see 
biology and have led to numerous advances in the field of biochemistry and in our 
understanding of molecular biology.[4] Over the subsequent decades since the elucidation 
of DNA, numerous discoveries have been made expanding our knowledge and 
understanding of molecular biology, including the undertaking of the human genome 
project. The determination of the sequence of the human genome has paved the way for 
many more discoveries, including: better understanding of the process of human 
evolution, the cause of disease and the interplay between environment and heredity in 
understanding human conditions.[5]  
DNA contains all the necessary information for life to function and multiply. The 
method of propagation of DNA in the cell is the main thesis of molecular inheritance and 
the detailed residue-by-residue transfer of the precise order of nucleotides within a DNA 
molecule, which are represented by the central dogma of molecular biology; DNA is 
transcribed into RNA, which is translated into protein (Scheme 1.1).   
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The ability to diagnose mutations in the genome that makes us prone to diseases is 
therefore a very desirable ability. These advances are being made in the field of 
molecular biology and biochemistry. Researchers are now capable of targeting DNA and 
mRNA by synthesizing a complementary oligomeric strand in order to stop transcription 
and translation respectively; this is the antigene and antisense strategy (Scheme 1.1). 
These strategies have the potential to be used as a genetic drug to “silence” certain genes, 
hence turning them “off” and preventing certain genetic diseases.  
 
Scheme 1.1: Information flow in biological systems 
The structure of DNA consists of the four nucleobases and a backbone made of 
alternating 2-deoxyribose sugar which is connected via phosphodiester bonds. The four 
nucleobases are thymine (T) and cytosine (C) which are classified as pyrimidines and the 
purines adenine (A) and guanine (G). The long polymeric units are made up of simpler 
units called nucleotides (Figure 1.1); which are the building blocks of nucleic acids. The 
joined subunits form an extensive polymer with the 5’-OH at one end and the 3’-OH at 
the other end (Figure 1.1). 
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The two strands run antiparallel to each other and are based paired through 
hydrogen bonds forming one of either A, B or Z-form DNA (Figure 1.2).[6] In the B-
DNA which contains the helical structure, there are two different types of grooves formed 
along the backbone when the two strands interact by base pairing. These grooves are 
designated as the major and minor grooves respectively, due to their sizes (Figure 1.2).[6] 
 
Figure 1.2: Schematic illustration of A-, B-, and Z-form DNAs. Also shown are the views of A-, B-, and Z-
form DNA down the helical axis. 
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Figure 1.1: Schematic of DNA polymer showing the repeating structure (nucleotide), 5'-phosphate 
group and 3'-hydroxyl group. The 'Base' on the sugar represents any of the four naturally occurring 
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  The repeating phosphate groups in the DNA backbone, gives the polymer an 
overall negative charge thus making it very water soluble. Due to the high electrostatic 
charge, there is a repulsive force associated with the binding of the two strands, which 
occurs by hydrogen bonding between the purine and pyrimidine nucleobases. The 
pyrimidines and purines hydrogen bond to each other such that the purine adenine forms 
two hydrogen bonds to the pyrimidine thymine, and the purine guanine forms three 
hydrogen bonds to the pyrimidine cytosine (Figure 1.3).  
 
Figure1.3: Illustration of the base pairs hydrogen bonding to each other via their Watson-Crick base 
pairing faces, with adenine (A) to thymine (T) and guanine (G) to cytosine (C). The sugar phosphate 
backbone of DNA is represented by ‘backbone’ in this schematic. 
1.1 Single nucleotide polymorphisms and their diagnosis 
Single nucleotide polymorphisms (SNPs) are a variation of the nucleobase at a 
single nucleotide. SNPs are the most common known form of human genetic variation 
and on average occurs once for every thousand nucleotides in the genome.[7] Figure 1.4 
shows a cytidine to thymine SNP in DNA.[8] SNP that occur within the coding sequence 
accounts for about 3 – 5% of a person’s DNA that is responsible for the translation of 
protein.[9] Most SNP occur outside the coding sequence, however the ones that occur 
within the coding sequence are of particular interest, because they can alter the biological 
functions of proteins resulting in desirable or undesirable traits which can make one, or 
one’s progeny susceptible to disease.[10] The ability to diagnose these permutations in the 
genome is therefore desirable.  
N
NN
N
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N N
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Figure 1.4: DNA strand 2 showing a single nucleotide cytosine (C) to thymine (T) polymorphism from 
DNA 1.[8] 
One of the most frequently used methodologies for the diagnosis of SNP employs 
the use of molecular probes based on Förster Resonance Energy Transfer (FRET) to 
monitor hybridization. A base discriminating fluorophore (BDF) containing probe that 
can selectively bind to its target sequence will result in a positive response upon 
hybridization and a negative response upon hybridization to its mismatch (Scheme 1.2). 
This methodology is preferred over the full sequencing of an amplified polymerase chain 
reaction (PCR) gene which is the archetypal method of SNP diagnosis; due to this 
methodology being costly and time consuming it is not preferred.[10] 
An application for these probes is their potential to be used in antigene and 
antisense strategies to stop transcription and translation respectively (Scheme 1.1), hence 
“turning off” the gene. Hudson’s group has used molecular probes based on FRET 
extensively for use in monitoring DNA hybridization.  
These molecular probes adopt a hairpin structure and consist of a fluorophore and 
quencher at opposing termini, a complimentary stem and a loop that is complimentary to 
its target (Scheme 1.3). Upon hybridization of the target to the loop region, the molecular 
probe stem unravels and the fluorophore is no longer quenched as quenching due to 
FRET is distance dependant; hybridization can therefore be tracked inside the cell by 
fluorescence microscopy using this technology.[10-11]      
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Scheme 1.2: Illustration of a positive response (fluorescence) of a base discriminating fluorophore (BDF) 
upon hybridization to its match versus its mismatch.[10] 
                 
Scheme 1.3: Illustration of FRET mechanism operation used in molecular beacon technology.[10] 
Traditionally, in Hudson’s group, the molecular probe strand consists of peptide 
nucleic acid (PNA) (Figure 1.5). PNA is an oligonucleotide analog that provides tight 
binding to complementary nucleic acid and is not susceptible to enzymatic degradation, 
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however it is not very water soluble.[1] PNA lack of solubility in water can be problematic 
for in-vivo studies in regards to the uptake of these molecular beacons into the cell.  
This project was focused on the synthesis of various fluorophores and quenchers 
that can be incorporated into DNA oligomers, hence addressing the water solubility issue 
of their PNA predecessors, as well as their ability to be used in molecular beacon 
technology based on FRET mechanism.      
    
Figure 1.5: Comparison of the structures of DNA (top) and PNA (bottom).[1] 
1.2 Nucleic acid analogues as molecular probes 
In biological, medicinal research and diagnostics, molecular probes have 
applications such as: the detection of single nucleotide polymorphisms (SNP),[12] 
quantitative real-time PCR,[13] molecular beacon technology,[14] high-throughput semi 
automated sequencing and microarray development.[1, 15] In order for this technique to be 
successful, a molecular probe that can selectively bind to the sequence of interest over 
other similar sequences is essential. The molecular probes must also be able to respond to 
hybridization in the form of a change in conductance or a fluorimetric response, among 
others.[16]  
In the Hudson group, hybridization of strands is monitored using fluorescence, 
which is a very powerful tool for detection due to its high sensitivity. In nucleic acid 
chemistry, fluorescent studies are most often done with luminescent tags such as 
rhodamine and fluorescein which are sometimes used in combination with a quencher 
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such as 4-(dimethylaminoazo)benzene (DABCYL) (Scheme 1.4)[17].[16b, 17]The ability of 
the fluorophore to be quenched by Förster Resonance Energy Transfer (FRET) is an 
important tool that is utilized to monitor hybridization. FRET is a nonradiative process 
that is distance dependant, in which the donor fluorophore transfers energy to the 
acceptor fluorophore and changes the fluorescence that is usually observed.[16b] This 
observed difference in fluorescence is due to the nonradiative transfer of energy from the 
donor to acceptor fluorophore. Luminescent tags such as fluorescein and rhodamine are 
disadvantageous, because they can perturb the system under investigation (due to their 
steric bulk) and their lack of polarity can disrupt the natural binding of the 
nucleobases.[17]   
 
Scheme 1.4: Representation of a fluorescent RNase H assay using a dual label system employing a 
fluorophore and a quencher.[17] 
Many luminescent modified nucleobases are derived from 7-substituted 7-
deazapurines and 5-substituted pyrimidines (Figure 1.6). These positions are generally of 
interest, because they are useful sites of manipulation due to established chemistry. The 
substituent is generally well tolerated in a duplex, because it is directed into the major 
groove and allows for Watson-Crick base pairing.[1] Typically, the fluorophore is 
incorporated into the oligomer that is complementary to the target.[10]  
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Figure 1.6: Structural example of the parent pyrimidine and purine showing the numbering system of the 
atoms. 
 According to a paper published in 2005 by the Hudson group, fluorescent 
nucleobases can be divided in three arbitrary classes (Figure 1.7): class I, II and III.[1] 
Class I as shown in figure 1.7 comprises of a pendant fluorophore that is separated 
electronically and spatially from the base pairing competent nucleobase. The use of 
conventional fluorescent moieties attached to the nucleobase through a flexible linker, 
allows for free movement of the fluorophore. The fluorimetric response from these 
fluorophores may therefore not be indicative of the actual hybridization state of the 
oligomers.[1] These types of molecules are capable of base pairing with the natural 
nucleobases, however, there may be steric interactions associated with the pendant 
fluorophore upon hybridization. The second class of nucleobase is compact, 
autofluorescent and since modification involves the Watson-Crick base pairing face, are 
base-pairing incompetent.[1] The third type of fluorescent nucleobase is of particular 
interest, because they are autofluorescent, are base pairing competent and have the ability 
to report on their environment upon hybridization, whilst not drastically perturbing the 
nucleic acid structure.[1] The number of base analogs that fulfill the requirements of class 
III are limited.[1]     
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Figure 1.7: Illustrative examples of arbitrary classes of fluorescent nucleobases. Class I: pendant 
fluorophore (circled), class II: non base-pairing analogs; class III base-pairing capable analog. 
1.3 Unnatural nucleic acid analogues  
The design and synthesis of nucleic acid analogues is a major field in medicinal 
chemistry, with applications such as nucleic acid detection and antiviral 
chemotherapeutics.[7] Naturally occurring DNA provides an excellent scaffold for the 
introduction of polycyclic aromatic hydrocarbons to provide particular desired properties 
such as fluorescence. These modifications, while producing desirable properties, must not 
hinder the Watson-Crick base pairing face to allow for proper base pairing geometries.[18]  
Of great interest in our group is the unnatural nucleobase pyrrolocytosine (pC), 
which can be achieved by the reaction of terminal alkynes to benzoyl protected 5-
iodocytosine via Sonogashira coupling, followed by an intramolecular cyclization 
reaction.[18] The pyrrolocytosine moiety itself is fluorescent and the fluorescence 
properties can be tuned based upon the substituent at the 6-position (Figure 1.8). Another 
important feature of pyrrolocytosine is that the Watson-Crick face pairing is not disturbed 
and the hydrogen bonding donor and acceptor properties of cytosine are maintained 
(Figure 1.8).     
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Figure 1.8: Illustration showing the H-bonding donor (D) and acceptor (A) properties of cytosine (C) and 
pyrrolocytidine (pC) analogs as well as the numbering system for pC. 
1.4 Palladium/copper catalyzed reactions 
The Sonogashira coupling[19] is an important and efficient carbon-carbon bond 
formation reaction, that was key for accessing the desired products reported in this thesis. 
It is a one pot catalytic variant of the Castro-Stephens[20] reaction (Scheme 1.5). Due to 
the mild reaction conditions and the number of products that makes use of aryl alkynes, 
the Sonogashira coupling has become a widely used reaction in synthetic organic 
chemistry. The reaction is thought to proceed with copper(I) iodide facilitating the 
deprotonation of the acetylene, generating the copper(I) acetylide in solution; the aryl 
undergoes oxidative addition to the palladium catalyst which is followed by a trans- 
metalation regenerating the copper(I) iodide catalyst in solution. A trans/cis isomerization 
occurs, followed by the reductive elimination to the product, regenerating the palladium 
catalyst (Scheme 1.6).   
 
    
Scheme 1.5: The Castro-Stephens reaction 
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Scheme 1.6: Catalytic cycle of the Pd/Cu Sonogashira reaction. 
1.5 6-substituted pyrrolocytidines versus 5-substituted 
pyrrolocytidines 
Our group has synthesized and studied the fluorescence properties of a number of 
6-substituted pyrrolocytosine nucleobases, as well as examined their binding properties to 
complement nucleic acids once incorporated into oligomers.[15, 21] Although studies of 6-
substituted pyrrolocytidines are still ongoing, it was decided to attempt the synthesis of a 
5-substituted pyrrolocytidine DNA nucleobase in order to be able to compare the two 
regioisomers (Figure 1.9).  
 
Figure 1.9: Illustration of a 5-substituted pC versus a 6-substituted pC. 
PdLn-2
Pd
L
L
XR
RX
oxidative
addition
Pd
R
L L
R'
CuX
Cu R'
NR"3HX
R"3N   + H R'
trans-
metalation
Pd
L
R
LR'
trans/cis
isomerization
R' R
reductive
elimination
PdLn
-2L
N
N
O
R
NH
N
N
O
R
NH
13 
 
1.6 Fluorescence quenching 
Fluorescence is a form of luminescence which involves the emission of 
ultraviolet, visible or infrared photons from an electronically excited state (Figure 
1.10).[22] When a singlet ground state molecule absorbs photons, it may be excited to 
higher energy levels. Once in these higher energy levels, the molecule can return to the 
ground state by several pathways including: emission by fluorescence, internal 
conversion (IC) and intersystem crossing (ISC) to the triplet state which is generally 
followed by phosphorescence. The energy dissipation back to the ground state can be 
radiative or nonradiative. Fluorescence and phosphorescence are both radiative processes, 
while the others are nonradiative.[23] 
 
Figure 1.10: Jablonski diagram showing the radiative and nonradiative transition between electronic states. 
The fluorescence emission occurs at lower energy compared to the absorbed 
energy. This phenomenon was first observed by George G. Stokes in 1852 at Cambridge 
and is now known as Stokes shift[22] (Figure 1.11). 
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Figure 1.11: Diagram showing the Stokes shift resulting from the difference between the absorption and 
emission spectra. 
The fluorescent emission resulting from the relaxation to the ground state is the 
basis for Förster Resonance Energy Transfer (FRET).[24] This excitation energy from the 
donor fluorophore can be transferred to a nearby acceptor fluorophore or quencher in a 
nonradiative manner. A quencher is a molecule with the capability to absorb the 
fluorescent signal from the donor fluorophore and not re-emit it as light. This relationship 
can be shown using a Stern-Volmer plot.  
 There are three different types of mechanisms for quenching: static, 
dynamic/collisional and apparent quenching.[25] In static quenching, a complex that is not 
fluorescent is formed between the quencher and fluorophore, whereas in dynamic 
quenching, the quencher has to diffuse towards the fluorophore while it is in its excited 
state and nonradiatively deactivate the excited state. Apparent quenching is not a true 
quenching process, but it may be due to absorption of emitted radiation by an excess 
concentration of fluorophore or by the presence of another absorbing species in the 
solution. This phenomenon is generally known as the “inner filter effect”.[25] For static or 
dynamic quenching to occur, there has to be interaction between the fluorophore and 
quencher.       
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1.7 Stern-Volmer plots 
The Stern-Volmer relationship allows us to explore the variation in fluorescence 
of an intermolecular photophysical process for a compound in the presence of a quencher. 
Stern-Volmer plots are a ratio of the fluorescence intensity of the sample in the absence 
of the quencher to the fluorescence intensity for that sample in the presence of the 
quencher, versus the concentration of the quencher. This variation in fluorescence is 
denoted by the well-known Stern-Volmer equation 1.[26] 
I0/I = 1 + Ksv [Q]   (equation 1) 
Where: I0 = fluorescence intensity of the sample in the absence of the quencher 
 I = fluorescence intensity of the sample when the quencher is present 
Ksv = Stern-Volmer constant 
 [Q] = concentration of the quencher 
 In dynamic quenching, the Stern-Volmer rate constant (Ksv) is equal to the 
product of the bimolecular quenching rate constant and the fluorescent lifetime of the 
excited state singlet of the fluorophore in the absence of the quencher. The Stern-Volmer 
rate constant is defined as: 
   Ksv = kq.τ0   (equation 2) 
Equation 1 can then be written as: 
    I0/I = 1 + kq.τ0 [Q]   (equation 3) 
The Stern-Volmer rate constant (Ksv) can be determined directly from the slope of the 
plot from equation 1. The gradient can be used to determine how effective the quencher is 
at quenching the fluorescence of the fluorophore.  
For the photophysical experiments reported in this thesis, the Ksv values were 
used to compare the efficiency of the quenchers.     
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1.8 Overview 
The research in the following chapters of this master’s thesis focuses on the 
synthesis of modified DNA nucleobases. Chapter II describes the attempted synthesis of 
5-phenylpyrrolocytidine nucleoside, as well as the motivation for the synthesis.  
Chapter III describes the synthesis of five 6-substituted pyrrolocytidines, as well 
as two aromatic alkynes: 1-ethynyl-4-nitrobenzene and a terminal alkyne that mimics the 
universal quencher DABCYL, which shall be incorporated in the synthesis of these 
pyrrolocytosines nucleobases. 
Chapter IV focuses on the quenching studies of various quenchers: one 6-
substituted DABCYL mimic pyrrolocytidine, a 6-(4-nitrophenyl)pyrrolocytosine ethyl 
ester and a 5-ethynyl cytosine ethyl ester. Their efficiencies as FRET pairs shall be tested, 
prior incorporation into oligomers.  
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Chapter 2  
2 Towards 5-phenylpyrrolocytidine 
2.1 Chapter Introduction 
To our knowledge, there has not been work reported on 5-substituted 
pyrrolocytidine nucleobases. The synthesis of a 5-phenylpyrrolocytidine nucleobase 
starting from 5-iodo-2’-deoxyuridine nucleobase (Scheme 2.1) was undertaken.  
The 6-aromatic substituted pyrrolocytidine was found to be very fluorescent and 
well tolerated when used as a molecular beacon. Upon incorporation into a duplex, it was 
found to have a stabilizing effect.[15, 17] Based on our group’s experience with 6-
substituted aromatic pyrrolocytidine nucleobases, questions regarding the fluorescent and 
stabilizing/destabilizing effect of the 5-substituted aromatic pyrrolocytidine nucleobase 
arose. The goal of this particular project was to determine which position on the 
pyrrolocytosine framework is most suitable for substituted aromatic groups and to study 
the stabilizing/destabilizing effects the 5-phenylpyrrolocytidine has in the duplex 
formation, if any.  
  
Scheme 2.1: Illustration of the starting material and the 5-phenylpyrrolocytidine nucleoside. 
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2.2 Results and Discussion 
For the synthesis of the 5-phenylpyrrolocytidine, 2’-deoxyuridine was chosen as 
the starting nucleobase of choice, as it is a less expensive starting material than 2’-
deoxycytidine and the use of protecting group chemistry was minimized.   
A shortcoming of uracil when used to make the fluorophore is its inability to form 
three hydrogen bonds with the complementary purine to cytosine (C) (Figure 2.1).  In 
order to overcome this shortcoming of the furanouridine nucleobase, an atom exchange is 
required to replace the oxygen atom with a nitrogen atom.  
 
Figure 2.1: Structural representation of cytosine (C), pyrrolocytosine (pC), furanouracil (fU) and uracil (U) 
showing their hydrogen bonding donor (D) and acceptor (A) properties. 
2.2.1 Synthesis of 5-(trimethylsilylethynyl)-3’,5’-diacetyl-2’-
deoxyuridine 
 The synthesis of this nucleoside starts with an acetylation of the sugar to impart 
solubility in organic solvents and for ease of purification by normal phase 
chromatography. The reaction was performed in pyridine and was catalyzed by DMAP 
and proceeded in excellent yield forming compound 1 (Scheme 2.2).[15]  
 The next step in this synthesis was a palladium and copper catalyzed reaction 
known as the Sonogashira coupling.[19] The reaction is sensitive to air, as the 
palladium(0) can be converted to palladium(II) oxide and becomes inactive as a catalyst. 
Therefore, it must be performed under deoxygenated conditions. Generally done in DMF, 
the reaction can be completed in THF as well, as it has a lower boiling point and is easier 
to remove after the reaction has gone to completion. The reaction was reproducible with 
good yields of 89% to produce compound 2 (Scheme 2.2). 
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Scheme 2.2: Schematic illustration of the synthesis of 5-(trimethylsilylethynyl)-3’,5’-diacetyl-2’-
deoxyuridine. Also, the schematic for the attempted synthesis towards two substituted furanouridine 
nucleobases are shown. 
Once compound 2 was synthesized, the next step was to perform the cyclization 
to the furanouridine nucleobase (Scheme 2.2, compound 3 or 4). The synthesis of 
compound 3 was thought to be a critical and important step towards the synthesis of the 
5-phenylpyrrolocytidine nucleoside. The ability to cyclize and simultaneously iodinate at 
the 5-position of the furanouridine nucleoside would provide a handle for a new carbon-
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carbon bond towards the 5-phenylfuranouridine nucleoside via the Suzuki coupling.[27] 
To that end, a 5-endo-dig electrophilic cyclization which has been reported by 
Dembinski[28] was attempted (Scheme 2.3). This method proved unsuccessful.  
  
Scheme 2.3: Synthetic scheme of the 5-endo dig cyclization reported by Dembinski. 
The reaction in Scheme 2.3 proceeds mechanistically by a nucleophilic ‘attack’ of 
the alkyne towards the electrophilic source of iodine. This results in a secondary 
carbocation (Scheme 2.4) that is stabilized by the phenyl group. This is then followed by 
the 5-endo-dig cyclization to produce the product in Scheme 2.3. 
 
 Scheme 2.4: Illustration of the nucleophilic attack of the alkyne towards the electrophilic source of iodine. 
The cyclization of compound 2 to 4 was attempted using a modified version of a 
5-endo-dig cyclization reported by Agrofoglio[29]. The reaction was run over a 48 hour 
period and for the first 24 hours the reaction was catalyzed by silver(I) nitrate (AgNO3). 
This was then followed by the addition of NIS in the hopes of achieving compound 3. 
After 24 hours, there was no observable progress in the reaction when checked by TLC. 
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More NIS was added and the following day a yellow precipitate had formed. The yellow 
precipitate was analyzed and determined not to be the product by 1H NMR. Since the 
reaction reported by Agrofoglio is an electrophilic cyclization, it is thought the Lewis 
acid nature of Ag+ activates the triple bond for an intramolecular attack of the oxygen 
towards the carbon-carbon triple bond (Scheme 2.5).[29]  
 
Scheme 2.5: Mechanism for the 5-endo-dig Ag+ catalyzed reaction proposed by Agrofoglio.[29] 
The 5-endo-dig cyclization in Scheme 2.3 and Scheme 2.5 reported by 
Dembinski[28] and Agrofoglio[29] respectively, contains a phenyl group which can help 
stabilize the cation formed through resonance after the addition of an electrophile across 
the triple bond compared to the trimethylsilyl substituent used. Silicon is also less 
electronegative than carbon; hence the trimethylsilyl substituent would be expected to 
donate electron density to the carbon-carbon triple bond through induction, making it less 
electrophilic. Another factor that may be contributing to the phenyl group reaction being 
more facile is its planar structure compared to the trimethylsilyl group, which is 
tetrahedral in geometry. The geometry of the TMS group coupled with its decreased 
electronegativity may sterically and electronically hinder the 5-endo-dig cyclization. 
Therefore, progress to the intermediate species (Scheme 2.6) may not have been 
favourable. The reaction was also attempted at a higher temperature using Et3N as the 
base with the same results as previously mentioned. The attempts towards the cyclization 
of compounds 3 and 4 are summarized in table 2.1. 
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Scheme 2.6: Illustration of the cationic intermediate that would be formed during the 5-endo-dig 
cyclization product.  
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Methodologies attempted 
for compound 3 
Duration of reaction Results 
NIS, Acetone Overnight Decomposition 
 AgNO3, Acetone/ then NIS 2 days Decomposition (yellow 
precipitate)  
NIS/AgNO3/THF/then NEt3/ 
then I2  
4 days Decomposition 
NIS/THF then added NEt3 
then heat to 40 °C 
2 days Decomposition 
Methodologies attempted for 
compound 4 
Duration of reaction Results 
AgNO3 /Acetone  overnight No reaction 
AgNO3 /Acetone  5 days No reaction 
AgNO3/Acetone/NEt3 / 40 °C  2 days Decomposition 
Table 2.1: Summarized table of results for the attempted synthesis of the fU (compounds 3 and 4) base. 
The initial attempts towards the cyclization of the furanouridine were met with no 
success and lead to the investigation of alternative methodologies. Since we have 
postulated an electronic effect caused by the trimethylsilyl group preventing cyclization, 
the possibility of carrying out the cyclization in the absence of the TMS group was 
investigated. The removal of the TMS group was done by treatment of compound 2 with 
tetra-n-butylammonium fluoride (TBAF) in THF to yield compound 5 (Scheme 2.7). 
Once compound 5 was obtained, the cyclization methodology proposed by Agrofoglio to 
synthesize compound 6 or 7 was used with no success (Scheme 2.8).[29] Variations of 
Agrofoglio’s methodology were attempted to simultaneously cyclize and iodinate at the 
5-position of the furanouridine (Table 2.2).  
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Scheme 2.7: Schematic of the desilylation reaction of compound 5. 
 
 
Scheme 2.8: Schematic of the attempted cyclization of compound 5 using Agrofoglio[29] methodology. 
Compound 6 was not synthesized using Agrofoglio[29] methodology at room 
temperature as the energy barrier to form the product using Ag+ may have been too high 
to overcome. The cyclization to compound 7 was attempted using NIS, similar to the 
methodology published by Dembinski[28] without success (Scheme 2.8). In order for 
compound 7 to be formed via the 5-endo-dig electrophilic cyclization, it would have to 
first form an unfavourable carbocation (Scheme 2.9). Since the chances of this 
intermediate being formed in solution were not very likely, the tandem cyclization and 
iodination at the 5-position of the furanouridine was not suitable using this methodology.   
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Scheme 2.9: Illustration of the unfavourable intermediate during the formation of compound 7.  
 
Methodologies Duration Results 
1) AgNO3, Acetonitrile overnight No reaction 
1) AgNO3, Acetone 
(5 days) 
2) NIS 
(1 day) 
6 days After the first step the starting 
material was unreacted. The addition 
of NIS in the second step yielded an 
unknown yellow precipitate. 
Table 2.2: Unsuccessful attempts towards the synthesis of compound 5 to 6. 
After a number of unsuccessful attempts to cyclize compounds 2 and 5 to the 
furanouridine, the methodology reported by Gamper’s group in 1996, in which a 
cyclization to the furanouridine starting from the unprotected 5-ethynyluridine 
nucleobase 5 (Scheme 2.10) was attempted.[30] Gamper’s methodology makes use of the 
copper(I) catalyst, which is well known to form a complex to the alkyne, making it more 
electrophilic. The first attempt to synthesize compound 7 using Gamper’s methodology 
was monitored using TLC. Once there was no evidence of the starting material, a one-pot 
synthesis towards the 5-iodo-furanouridine nucleobase (compound 7, Scheme 2.8) was 
attempted. The synthesis of compound 7 was unsuccessful and the reaction was done a 
second time and worked up after the disappearance of the starting material to yield 
compound 6 (Scheme 2.10) in low yields. The reaction of compound 5 to 6 was not 
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favourable at room temperature and was driven thermally at high temperature. The 
catalyst lowered the activation energy of the reaction, whilst the temperature increased 
the rate of the reaction, making it feasible. 
                     
Scheme 2.10: Schematic illustration for the synthesis of compound 6 from compound 5. 
Once compound 6 was obtained,  the synthesis of compound 8 (Scheme 2.11) 
was the next step towards the furanouridine monomer. The reaction was attempted in 
acetonitrile using 1.5 equivalence of N-iodosuccinimide (NIS) and was left to run to 
completion overnight. The reaction was then monitored the following day by TLC and 
the starting material was still observed as a single spot, indicating no reaction. Due to the 
unresponsive nature of the nucleophile towards the electrophilic iodine source, it was 
attributed to the 5-position on the furanouridine being less nucleophilic than the 5-
position on the pC. This reasoning was made on the basis that oxygen is more 
electronegative than nitrogen, making the 5-position less nucleophilic. 
O
OAc
AcO N
NH
O
O
5
O
OAc
AcO N
N
O
O
7
I
O
OAc
AcO N
N
O
O
6
1) CuI
    NEt3
    DMF, 120 °C, N2
2) NIS
    Acetone
    overnight
92%
CuI
NEt3
DMF
120 °C, N2
33%
27 
 
    
Scheme 2.11: Schematic of the attempted iodination and atom exchange on the fU nucleobase. 
The furanouridine nucleobase resembles the benzofuran ring (Figure 2.2) and 
their reactivity was expected to be similar, because of their molecular similarities. A 
literature search for the iodination of the benzofuran ring at the 3-position and 
unsubstituted at the 2-position resulted in no published work. Iodination at the 3-position 
of the benzofuran ring resulted in no results, either because no one has been able to 
iodinate at that position due to the reasons mentioned above, or it has not been attempted, 
which seems less likely. However, the pC scaffold was expected to be more nucleophilic 
at the 5-position compared to the 3-position of the furanouridine nucleobase. Based on 
that hypothesis, the literature was searched for reactions that involved the iodination of 
the indole ring (Figure 2.2), because of its similarity to the pyrrolocytosine nucleobase. 
This search resulted in several literature procedures confirming the hypothesis of the 
difference in reactivity at the 3- and 5-position of the fU and pC nucleobase respectively 
(Figure 2.2). The paper published by Zolfigol[31] reported the iodination at the 3-position 
of the indole ring (Scheme 2.12).    
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Figure 2.2: Illustration of the comparison between the fU and benzofuran as well as the pC and indole ring. 
   
Scheme 2.12: Illustration of the iodination at the 3-position of the indole reaction reported by Zolfigol.[31] 
Based on the inability to iodinate at the 3-position of the fU nucleobase and the 
knowledge that the best approach was to try iodinate the at the 5-position of the pC 
nucleobase, the synthesis of compound 9 (Scheme 2.11) was then attempted using a 
literature procedure that made use of aqueous ammonia at room temperature.[30] After 24 
hours the reaction was stopped and the crude product was analysed by 1H NMR, which 
indicated that there was a mixture of compound 9 and the deacetylated starting material 6 
(Scheme 2.11). The crude product was then redissolved in the aqueous ammonia and the 
mixture was heated at 50 °C overnight. The crude product was then analysed, at which 
point the reaction mixture had gone to an intractable material. 
The synthesis of compound 9 was attempted using another literature procedure, 
which involved concentrating a solution of methanol with ammonia (Scheme 2.11).[15] 
Based on the knowledge gained from the previous amination reaction, the reaction was 
monitored for the deacetylation of the nucleoside. Once all the acetylated starting 
material had disappeared, the unprotected furanouridine nucleobase disappearance was 
monitored for evidence that the reaction had gone to completion. After 28 hours, there 
was one fluorescent spot on the baseline of the TLC (eluent 90% CH2Cl2: 10% MeOH), 
that was believed to be the product. The analysis of the crude product by 1H NMR after 
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drying looked promising. The NMR spectrum was complicated indicating a mixture, but 
the peaks corresponding to the pC nucleobase were observed. Attempted purification by 
column chromatography proved unsuccessful. 
2.3 Conclusion 
The synthesis towards the 5-phenylpyrrolocytodine nucleobase starting from the 
5-iodo-2’-deoxyuridine was challenging and the final product was not attained. Once the 
Sonogashira coupled product was obtained, attempts to use methodologies reported by 
Dembinski, Agrofoglio, as well as variations of their procedures to the furanouridine 
nucleobase were unsuccessful.  
The furanouridine, however, was attained in low yield by using the methodology 
reported by the Gamper group. Iodination at the 5-position of the furanouridine was 
unsuccessful using an electrophilic source of iodine. The amination of the furanouridine 
(6) to the pyrrolocytidine (9) looked promising when analyzed by 1H NMR. However, the 
crude material was not successfully purified. 
2.4 Future Outlook 
The ability to successfully synthesize the 5-phenylpyrrolocytidine would be an 
exciting step towards synthesizing a series of 5-substituted pyrrolocytidines. Although 
the final product was not attained, much was learned about the synthesis towards these 5- 
substituted pyrrolocytidines, such as: the difficulty associated with the cyclization in the 
presence of the TMS group and iodinating at the 5-position of the furanouridine ring, 
which has laid the groundwork for future endeavors.  
2.5 Experimental 
 All chemicals used were obtained from commercial sources, and used without 
further purification, except for pyridine which was purified by distillation using CaH2. 
Thin layer chromatography was performed on Merck Kieselgel F-60 plates, and flash 
column chromatography was performed on Merck Kieselgel 60, 230-400 mesh. Proton 
General experimental procedures 
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chemical shifts are reported in parts per million from tetramethylsilane (0 ppm), and are 
referenced to the residual proton in the deuterated solvents: DMSO-d6 (2.50 ppm) and 
CDCl3 (7.27 ppm) for 1H NMR. Solution 1H NMR was obtained using a Mercury 400 
MHz spectrometer and an Inova 600 MHz at room temperature. 13C NMR were recorded 
at 100 MHz. Peak multiplicities are described as; s (singlet), d (doublet), ddd (doublet of 
doublet of doublet), dt (doublet of triplet), t (triplet), q (quartet), m (multiplet) and br. s 
(broad singlet). Coupling constants (J) are reported in Hertz (Hz). High resolution mass 
spectra (HRMS) were obtained using electrospray ionization time of flight methods (ESI-
TOF).   
2.5.1 Synthesis of 3’,5’-diacetyl-2’-deoxyfuranouridine 
5-iodo-3’, 5’-diacetyl-2’-deoxyuridine (1) 
5-iodo-2’-deoxyuridine (1.00 g, 2.82 mmol) was dissolved in 20 ml pyridine in a 
round bottom flask at room temperature. To this mixture was added acetic anhydride 
(1.33 ml, 14.1 mmol) and N, N-dimethyl-4-aminopyridine (DMAP) (catalytic). The 
reaction mixture was left to stir overnight under a nitrogen atmosphere. On completion, 
the solvent was removed in vacuo and an extraction was done with aqueous sodium 
bicarbonate and dichloromethane (CH2Cl2). The organic layer was then dried with 
sodium sulphate (Na2SO4) and then it was filtered and dried to yield 5-iodo-3’,5’-
diacetyl-2’-deoxyuridine ( 1.22 g, 2.78 mmol). Characterization of 1H NMR was 
consistent with that reported for this known compound. [9] Yield: 98% 
1H NMR (400 MHz, CDCl3) δ ppm 8.98 (s, 1 H) 6.30 (dd, J=8.4, 5.7 Hz, 1 H) 5.24 (dd, 
J=6.5, 2.3 Hz, 1 H) 4.27 - 4.46 (m, 3 H) 2.55 (ddd, J=14.3, 5.7, 2.0 Hz, 1 H) 2.09 - 2.25 
(m, 7 H); TLC Rf = 0.38 in DCM: MeOH; 95:5 
 5-trimethylsilylethynyl-3’,-5’-diacetyl-2’-deoxyuridine (2) 
5-iodo-3’,5’-diacetyl-2’-deoxyuridine (0.30 g, 0.685 mmol), copper(I) iodide 
(0.26 g, 0.137 mmol) and tetrakis(triphenylphosphine)palladium(0) were added to 12 ml  
of tetrahydrofuran (THF) in a round bottom flask and degassed at -78 °C (x3). To this 
mixture was added triethylamine (NEt3) (0.38 ml, 2.74 mmol) and trimethylsilylacetylene 
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(0.15 ml, 1.03 mmol); then the reaction mixture was degassed again (x3). The reaction 
was then stirred in the absence of light under a nitrogen atmosphere for 24 hours. After 
completion, the reaction was dried by rotary evaporation and then a liquid/liquid 
extraction was done with ethylenediamine tetraacetic acid (EDTA) in CH2Cl2 (x3). The 
organic layer was then dried with Na2SO4 and filtered off, then dried by rotary 
evaporation. The crude product was subjected to column chromatography. The eluent 
consisted of a mixture of CH2Cl2: methanol (MeOH), which was used as a gradient 
beginning with 0% MeOH, then moving up to 2% MeOH. The fractions of interest were 
dried in vacuo to yield 5-trimethylsilylethynyl-3’,-5’-diacetyl-2’-deoxyuridine (0.25 g, 
0.612 mmol). Characterization of 1H NMR was consistent with that reported for this 
known compound. [9] Yield: 89% 
1H NMR (400 MHz, CDCl3) δ ppm 8.82 (br. s., 1 H) 7.84 (s, 1 H) 6.33 (dd, J=7.8, 5.9 
Hz, 1 H) 5.25 (dd, J=3.9, 2.3 Hz, 1 H) 4.33 - 4.41 (m, 2 H) 4.28 - 4.31 (m, 1 H) 2.53 (dd, 
J=14.4, 5.8, 2.2 Hz, 1 H) 2.16 - 2.25 (m, 4 H) 2.12 (s, 3 H) 0.22 (s, 8 H); Rf = 0.59 in 
DCM: MeOH; 9:1 
5-ethynyl-3’, 5’-diacetyl-2’-deoxyuridine (5) 
To a round bottom flask was added 5-trimethylsilylethynyl-3’,5’-diacetyl-2’-
deoxyuridine (0.247 g, 0.605 mmol) and tetra-n-butylammonium fluoride (TBAF) (0.7 
ml, 0.666 mmol). The mixture was dissolved in 5 ml of dry THF and left to stir in the 
absence of light for 3.5 hours. The solvent was dried in vacuo and then the crude product 
was subjected to flash column chromatography. The eluent consisted of a mixture of 
CH2Cl2: methanol (MeOH), which was used as a gradient beginning with 0.5 % MeOH, 
then moving up to 6% MeOH. The fractions containing the product were combined and 
removed in vacuo to yield 5-ethynyl-3’, 5’-diacetyl-2’-deoxyuridine (0.187 g, 0.556 
mmol). Characterization of 1H NMR was consistent with that reported for this known 
compound. Yield: 92%  
1H NMR (400 MHz, CDCl3) δ ppm 8.45 (br. s., 1 H) 7.92 (s, 1 H) 6.31 (dd, J=7.8, 5.9 
Hz, 1 H) 5.22 - 5.27 (m, 1 H) 4.36 - 4.44 (m, 2 H) 4.29 - 4.35 (m, 1 H) 3.22 (s, 1 H) 2.57 
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(ddd, J=14.2, 5.8, 2.3 Hz, 1 H) 2.19 - 2.26 (m, 1 H) 2.18 (s, 3 H) 2.13 (s, 3 H); Rf = 0.52 
in DCM: MeOH; 9: 1 
3’, 5’-diacetyl-2’-deoxy-furanouridine (6) 
To a two necked flask containing dry dimethylformamide (DMF) was added 5-
ethynyl-3’,5’-diacetyl-2’-deoxyuridine (0.42g, 1.25 mmol) and copper(I) iodide (0.0524 
g, 0.275 mmol). The reaction was degassed at -78 °C (x3). To this mixture was added 
triethylamine (1.57 ml, 11.25 mmol) and the reaction was heated under nitrogen at 120oC 
for two hours adding copper(I) iodide (0.262 g, 0.138 mmol) every half hour. The 
reaction was stopped after two hours and the solvent was removed in vacuo. The crude 
product was re-dissolved in CH2Cl2 and an extraction was done in water (x3). The 
organic layer was then collected and dried using Na2SO4, then it was filtered. The volume 
was reduced in vacuo and the product was precipitated out of hexane to yield 3’, 5’-
diacetyl-2’-deoxyfuranouridine (0.14 g, 0.416 mmol). Characterization of 1H NMR was 
consistent with that reported for this known compound. [10] Yield: 33%  
1H NMR (400 MHz, CDCl3) δ ppm 8.40 (s, 1 H) 7.37 (d, J=2.3 Hz, 1 H) 6.56 (d, J=2.3 
Hz, 1 H) 6.25 - 6.35 (m, 1 H) 5.22 (d, J=5.9 Hz, 1 H) 4.41 (s, 3 H) 2.91 - 3.04 (m, 1 H) 
2.07 - 2.14 (m, 5 H) 2.05 (s, 3 H); Rf = 0.47 DCM: MeOH; 9: 1 
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Chapter 3  
3 Synthesis of 6-substituted pyrrolocytidines 
3.1 Chapter Introduction 
The 6-substituted pyrrolocytidines are intrinsically fluorescent nucleobases that 
falls into the class III base-pairing capable analogs (Chapter 1.1, Figure 1.5). The 
unsubstituted pyrrolocytidine nucleobase by itself is fluorescent, but it was found that 
greater fluorescence emission occurred when the substituent at the 6-position was 
aromatic.[15] This finding lead to the investigation of a 6-phenylpyrrolocytosine 
nucleobase in our group as a potential base discriminating probe.[15] The fluorescence of 
these 6-phenylpyrrolocytosine (PhpC) can be tuned electronically based on the 
substitutions on the phenyl ring to intensify, or quench the fluorescence.  
The cyclization to the pyrrolocytosine fluorophore is achieved through a 5-endo-
dig cyclization (Scheme 3.1). Our group has investigated a wide variety of 6-substituted 
pyrrolocytosines in regards to their synthesis and fluorescent studies. This research was 
meant to extend these studies by investigating the synthesis, as well as the photophysical 
properties of various 6-substituted pyrrolocytidine that were expected to have fluorescent 
and quenching properties to be incorporated into DNA oligomers for use as molecular 
probes. These pyrrolocytidines, once incorporated into DNA oligomers will be water 
soluble hence addressing the aqueous solubility of their pyrrolocytosine predecessors 
which contained different N3-position substituent. 
    
Scheme 3.1: Schematic representation of the 5-alkynylcytidine via the 5-endo-dig cyclization to the 
pyrrolocytidine nucleobase (A) and subsequent removal of the benzoyl group (B). 
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3.2 Results and Discussion 
3.2.1 Synthesis of aromatic alkynes 
One of the 6-substituted pyrrolocytidines of interest in the series to be synthesized 
and studied is the para-nitrobenzene. The nitro group is expected to quench the 
fluorescence of the pyrrolocytidine, making the 6-(4-nitrobenzene)pyrrolocytidine a 
quencher. The synthesis of compound 11 (Scheme 3.2) started with the commercially 
available 4-iodonitrobenzene, which was subjected to Sonogashira coupling conditions in 
tetrahydrofuran (THF) to yield compound 10 [19] in good yields. Once compound 10 was 
obtained, the next step was the removal of the trimethylsilyl group to form the desired 
alkyne. The deprotection was first done using TBAF in THF, which proceeded in very 
low yields, due to the quality of the TBAF. The crude, desired compound 11 was then 
obtained by reacting compound 10 with potassium carbonate (K2CO3) in methanol. 
 Silicon has an affinity for oxygen, because its two unpaired 3P orbitals are shared 
with the two 2P orbitals of oxygen, thus completing the 2P orbitals of oxygen. Due to this 
affinity, the deprotection of the trimethylsilyl group in methanol is thought to proceed by 
a nucleophilic attack of the methoxide forming the pentavalent coordinate intermediate 
(Scheme 3.3). This will then form the unprotected alkyne in the presence of a proton 
source. Due to the propensity of some alkynes to polymerize under acidic conditions, the 
purification of compound 11 using silica gel purification was done carefully using a short 
column. 
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Scheme 3.2: Schematic of the synthetic methodology used to obtain compound 11. 
 
Scheme 3.3: Mechanism for the deprotection of trimethylsilyl in methanol with potassium carbonate. 
Another alkyne of particular interest is the DABCYL mimic, (4-((N,N-
(dimethylamino)phenyl)azo)benzene)acetylene. DABCYL is known as the universal 
quencher[32] and it has found usage in molecular beacon technology.[33] The mimic, 
compound 14, once incorporated into the pyrrolocytidine was expected to be an efficient 
azopyrrolocytidine based quencher.  
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The synthesis started with the diazonium coupling of the commercially available 
4-iodoaniline and N,N-dimethylaniline (Scheme 3.4). The 4-iodoaniline was first 
dissolved in a 3 M solution of warm hydrochloric acid (HCl), due to its limited solubility 
at room temperature. The 4-iodoaniline was then converted to a diazonium salt using 
sodium nitrite (NaNO2). The solution was slowly added to a 1M HCl solution of N,N-
dimethylaniline to form the desired product 12, via an electrophilic aromatic substitution 
(Scheme 3.5). Initial attempts at isolating the product resulted in low yields, however the 
yield was improved to 56%, which is closer to the reported yield of 70%.[34] Scheme 3.5 
shows the proposed mechanism for the formation of compound 12. 
 
Scheme 3.4: Synthetic illustrations for the synthesis of the DABCYL mimic alkyne 14. 
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Scheme 3.5: Proposed mechanism for the formation of compound 12 via the diazonium salt, where ‘B’ 
stands for base. 
 The synthesis towards compound 14 proceeded by subjecting compound 12 to 
Sonogashira coupling[19] conditions to form compound 13. Compound 13 was obtained in 
moderate to high yields of 70% - 92%. Once compound 13 was purified by column 
chromatography, the compound was subjected to basic conditions in methanol using 
potassium carbonate for the deprotection of the TMS group, yielding the desired azo 
alkyne in 89%. 
3.2.2 Synthesis of 6-substituted pyrrolocytidine nucleobases 
The synthesis towards the various 6-substituted pyrrolocytidines started with the 
acetylation of the 2’-deoxycytidine nucleoside (Scheme 3.6). This was done in 
chloroform using glacial acetic acid and acetyl chloride. The reaction proceeded in very 
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good yields and compound 15 was isolated in 91% yield after purification by column 
chromatography.   
Iodination of the acylated 2’-deoxycytidine (compound 15) was done in water 
using chloroform and glacial acetic acid. The purpose of this iodination reaction was to 
provide the nucleobase with a “handle” for the Sonogashira coupling reaction, which 
requires an aryl or vinyl halide.[19] The iodination was performed using 0.6 equivalence 
of iodine (I2) and 0.2 equivalence of iodic acid (HIO3). The I2 was not used in 
stoichiometric amount in this reaction, because it was regenerated in-situ by HIO3 as the 
reaction progressed. The reaction proceeded in low to moderate yields of up to 67% to 
obtain compound 16. 
Protection of the exocyclic amine of compound 16 to form compound 17 is a key 
step towards the synthesis of the pyrrolocytosine. In the Hudson group, while studying 5-
iodonucleobases with terminal alkynes, it was noted that under mildly forcing conditions 
the adjacent heteroatoms underwent a cyclization with the 5-alkynyl substituents to yield 
furanouracils and pyrrolocytosines.[35] Mild basic conditions will deprotect the amide 
hydrogen and the coordination of copper(I) with the 5-alkynyl increases its 
electrophilicity, leading to the cyclization reaction. The synthesis of compound 17 was 
performed in anhydrous pyridine under a nitrogen atmosphere, since the benzoylation is 
sensitive to moisture, yielding the desired product in moderate yields. 
The synthesis to the pyrrolocytidine from compound 17 is a one pot two step 
synthesis, which started with the Sonogashira coupling[19] between the terminal alkyne 
and the 5-iodocytidine nucleobase. At a temperature of 50 °C, 24 hours is generally 
enough for the tandem coupling and ortho- heteroatom to facilitate an attack towards the 
5-substituted alkyne to form the pyrrolocytidine nucleobase. Once the cyclization to the 
pyrrolocytidine was completed, the removal of the benzoyl was done using anhydrous 
ethanol (Anhyd. EtOH) in triethylamine (Et3N) to yield compound 18a,b,c,d and e.   
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Scheme 3.6: Synthetic scheme towards the various 6-substituted pyrrolocytidine nucleobases. 
 For the synthesis of compound 18c trimethylsilylacetylene underwent the tandem 
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trimethylsilyl group at the 6-position of the pyrrolocytidine was not stable under these 
reaction conditions. This was not surprising since the trimethylsilyl is removed under 
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deprotection of the benzoyl group (Scheme 3.1, reaction B) to afford the unprotected 
pyrrolocytidine. 
The incorporation of electron withdrawing aromatic alkynes into the 
pyrrolocytidine scaffold resulted in slower annulation in comparison to the electron 
donating aromatic alkynes, which may be due to the ability of the alkyne to donate 
electrons to the Lewis acid. The tandem coupling and cyclization of 1-ethynyl-4-
nitrobenzene to compound 17 yielded the 6-(4-nitobenzene)pyrrolocytidine in low yields 
following the conventional 48 hours reaction time. Due to the slower reaction time of the 
electron withdrawing aromatic alkyne, the reaction time was increased to seven days in 
order to improve the yield. The Hudson group had previously reported a minimum 
reaction time of six days for these electron withdrawing substituents, due to their 
decreased reaction times.[36] As reported in the literature, microwave-assisted 
Sonogashira coupling[37] was utilized as a non conventional energy source to reduce the 
reaction time. Raut and co-worker reported the microwave assisted Sonogashira coupling 
towards 2-[6-arylethynyl)pyridin-3-yl]-1H-benzimidazole using microwave technology 
(Scheme 3.7) in 87% yield.[37] They reported the successful Sonogashira coupling for 
trimethylsilylacetylene after 5 minutes at 100 °C,[37] therefore the coupling reaction was 
attempted at temperatures of 120 – 150 °C for 5 – 10 minutes, because of the electron 
withdrawing nature of the aromatic alkyne. The deprotection of the benzoyl group was 
attempted conventionally at 50 °C overnight in anhydrous ethanol. The reaction was not 
successful when done in the microwave under these reaction conditions.  
The attempt to incorporate 4-ethynylbenzonitrile into the pyrrolocytidine was 
unsuccesful. The cyclized product was not obtained after the reaction was worked-up and 
1H NMR analysis of the isolated fractions from column purification indicated no coupled 
product either. The starting material was not recovered since it was consumed based on 
the monitoring of the reaction by TLC.   
 The synthesis of compound 19a was achieved by the deprotection of the 3’- and 
5’-hydroxyl groups using K2CO3 in MeOH. This step was done to obtain the unprotected 
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nucleobase to perform further studies. Compound 19a was then purified via column 
chromatography using 10% MeOH in DCM. 
 
Scheme 3.7: Synthetic scheme of  2-[6-arylethynyl)pyridin-3-yl]-1H-benzimidazole using microwave 
technology reported by Raut.[37] 
3.3 Conclusion 
Two aromatic alkynes: 11 and 14 were synthesized using the Sonogashira 
coupling methodology to incorporate the trimethylsilylacetylene. This was then followed 
by the deprotection of the trimethylsilyl group. Compound 11 and 14 were then 
successfully incorporated into the pyrrolocytidine scaffold to afford compounds 18e and 
18a, respectively. Three other 6-substituted pyrrolocytidines were synthesized: 18b, 18c 
and 18d. The attempt to incorporate the 4-ethynylcyanobenzene electron withdrawing 
aromatic substituent was unsuccessful.  
3.4 Future Outlook 
Synthesis of the pyrrolocytidine nucleosides on a larger scale to be able to 
synthesis the phosphoramidite (Scheme 3.8), after which they can be incorporated into 
DNA oligomers to be used in molecular beacon technology. Further studies using 
microwave technology to perform the tandem coupling and cyclization to the 
pyrrolocytidine with electron withdrawing substituents would be an asset in order to 
reduce reaction time. 
N
H
N
N
Cl + H Si
1) Pd(PPh3)2Cl2, CuI
    Et3N, DMSO, MW,
    100 oC, 5 min
2) NaOH, MeOH
N
H
N
N
H
42 
 
 
Scheme 3.8: Scheme of the synthesis from the pyrrolocytidine nucleoside to the phosphoramidite 
derivative. 
3.5 Experimental 
3.5.1 Synthesis of the para-nitrobenzene acetylene (11) 
Trimethyl((4-nitrophenyl)ethynyl)silane (10) 
To a 100 ml round bottom flask were added 4-iodonitrobenzene (8.03 mmol, 2.00 
g) and 15 ml of tetrahydrofuran. The reaction was then degassed at -78 °C using an 
acetone and dry ice bath. To that were added copper(I) iodide (2.41 mmol, 0.4588 g) and 
tetrakis (triphenylphosphine) palladium(0) (0.803 mmol, 0.9279 g) and the reaction was 
then degassed again. Triethylamine (32.1 mmol, 4.48 ml) and trimethylsilylacetylene 
(16.1 mmol, 2.29 ml) were then added to the reaction and the mixture was left to run to 
completion overnight under a nitrogen atmosphere in the absence of light. The reaction 
was stopped the following day and the solvent was removed in vacuo. The crude product 
was then purified by column chromatography using a gradient of 2.5% - 5% ethyl 
acetate: hexane. The fractions containing the product were collected and dried to obtain 
compound 10 in 73% (5.84 mmol, 1.28 g). 
1H NMR (400 MHz, CDCl3) δ ppm 8.18 (d, J=9.0 Hz, 2 H) 7.60 (d, J=9.0 Hz, 2 H) 0.28 
(s, 10 H); 13C NMR (101 MHz, CDCl3) δ ppm 147.4, 133.0, 130.3, 123.8, 103.0, 100.9, 
77.6, 77.3, 0.2 
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1-ethynyl-4-nitrobenzene (11) 
 To a flask containing compound 10 (3.92 mmol, 0.86 g) were added 18 ml of 
methanol and potassium carbonate (0.784 mmol, 0.1084 g). The reaction was stirred for 
half an hour, after which it was stopped. The solvent was removed in vacuo and the crude 
product was run quickly through a short column using a 1:1 mixture of dichloromethane: 
ethyl acetate as the eluent. The fraction containing the product were collected and dried 
to obtain compound 11 (3.47 mmol, 0.51 g) in 88% yield. 
1H NMR (400 MHz, CDCl3) δ ppm 8.20 (d, 2 H) 7.64 (d, 2 H) 3.37 (s, 1 H); 13C NMR 
(101 MHz, CDCl3) δ ppm 132.6, 128.6, 123.2, 122.0, 82.0, 81.3, 76.7, 76.4; HRMS (ESI) 
calculated for [C8H5NO2] +: 147.1308, Found 147.1310. 
3.5.2 Syntheses of the DABCYL mimic alkyne (14) 
 4-iodoaniline (2.20 g, 10.0 mmol) was dissolved in a 3.5 M hydrochloric acid 
solution. The solution was then cooled rapidly to 0 °C to precipitate the anilinium 
hydrochloride as a microcrystalline solid. To this was added sodium hydrogen sulfite 
(NaHSO3) (0.0145 g, 0.139 mmol). An ice cold solution of sodium nitrite (NaNO2) (0.69 
g, 10.0 mmol) in water (10 ml) was added drop wise to the stirred suspension. After 15 
minutes, the resulting yellow solution of the diazonium species was added drop wise to a 
stirred solution of N,N-dimethylaniline (1.21 g, 10.0 mmol) in a 1 M HCl (11 ml) 
solution. The mixture was stirred for 30 minutes and the reaction was kept between 0 to 5 
°C during the entire procedure. A saturated aqueous solution of Na2CO3 was added until 
the evolution of CO2 stopped. To this mixture was added 50 ml of brine and the brown 
solid was isolated by filtration. The crude product was purified by silica column 
chromatography using chloroform as the eluent to afford compound 12 in 56% yield 
(1.97 g, 5.61 mmol). 
1H NMR (400 MHz, CDCl3) δ ppm 7.88 (d, J=9.4 Hz, 2 H) 7.81 (d, J=8.6 Hz, 2 H) 7.59 
(d, J=8.6 Hz, 2 H) 6.76 (d, J=9.4 Hz, 2 H) 3.10 (s, 6 H); 13C NMR (101 MHz, CDCl3) δ 
ppm 152.3, 152.2, 143.1, 137.7, 124.8, 123.6,  111.1, 94.9, 76.7, 76.4, 40.0; HRMS (ESI) 
calculated for [C14H14IN3]+ : 351.1855, Found 351.1852. 
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 ((4-((N,N-(dimethylamino)phenyl)azo)benzene)ethynyl)trimethylsilyl (13) 
 To a 50 ml round bottom flask was added compound 12 (0.58 g, 1.65 mmol) and 
12 ml of DMF. The mixture was then degassed at -78 °C and tetrakis 
(triphenylphosphine)palladium(0) (0.1907 g, 0.17 mmol) and copper(I) iodide (0.0628 g, 
0.33 mmol) were added and the mixture was degassed again. Triethylamine (0.92 ml, 
6.60 mmol) and trimethylsilyl acetylene (0.47 ml, 3.30 mmol) were then added to the 
reaction and the mixture was left to run to completion in the absence of light. Once the 
reaction was complete, an extraction was done using 2% aqueous disodium 
ethylenediamine tetraacetate in dichloromethance (CH2Cl2). The CH2Cl2 layer was 
collected and dried using sodium sulfate (Na2SO4). The organic layer was then separated 
by filtration and the organic layer was dried to produce the crude product. The product 
was then isolated by using silica gel chromatography, eluent conditions 30% CH2Cl2:  
hexanes. The product was isolated in 92% to yield compound 13 (0.53 g, 1.65 mmol). 
1H NMR (400 MHz, CDCl3) δ ppm 7.89 (d, J=9.0 Hz, 2 H) 7.80 (d, J=8.6 Hz, 2 H) 7.58 
(d, J=8.6 Hz, 2 H) 6.76 (d, J=9.4 Hz, 2 H) 3.10 (s, 6 H) 0.29 (s, 8 H); 13C NMR (101 
MHz, CDCl3) δ ppm 152.6, 152.6, 143.6, 132.7, 125.2, 123.8, 122.1, 111.5, 105.1, 95.9, 
77.3, 76.7, 40.3, 0.0; HRMS (ESI) calculated for [C19H23N3Si]+ :321.1661, Found 
321.1667. 
 DABCYL mimic alkyne (14)  
To a 50 ml round bottom flask was added compound 13 (0.20 g, 0.622 mmol) and 
12 ml of methanol. To that was added potassium carbonate (0.0172 g, 0.124 mmol) and 
the reaction was left to run to completion at room temperature. The reaction was left to 
run for three hours after which it was stopped and the solvent was removed in vacuo. The 
crude product was dissolved in hexane and filtered. The filtrate was collected and dried to 
produce the desired product 14 in 92% yield (0.16 g, 0.642 mmol).  
1H NMR (400 MHz, CDCl3) δ ppm 7.89 (d, J=9.4 Hz, 2 H) 7.81 (d, J=8.6 Hz, 2 H) 7.61 
(d, J=8.6 Hz, 2 H) 6.76 (d, J=9.4 Hz, 2 H) 3.20 (s, 1 H) 3.10 (s, 7 H); 13C NMR (101 
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MHz, CDCl3) δ ppm 152.9, 152.6, 143.6, 132.9, 125.2, 122.7, 122.1, 111.5, 83.7, 78.6, 
77.3, 76.7, 40.3; HRMS (ESI) calculated for [C16H15N3]+ : 249.3104, Found 249.3108.  
3.5.3 Synthesis of 6-substituted pyrrolocytidines (18) 
3’, 5’-diacetyl-2’-deoxycytidine (15) 
In a round bottom flask was added deoxycytidine (1.00 g, 3.79 mmol) and glacial 
acetic acid (CH3COOH) (10 ml). The mixture was heated at 35 °C until dissolution. The 
mixture was then brought to room temperature and a mixture of chloroform (CHCl3) (8 
ml) and acetyl chloride (AcCl) (3 ml) were added. The reaction was then left to run to 
completion overnight at room temperature. The solvent was then removed in vacuo and 
the crude product was purified by flash column chromatography: eluent conditions, 
methanol: ethyl acetate (EtOAc) 2: 8. The fractions containing the product were 
combined and the solvent was removed in vacuo to yield 3’, 5’-diacetyl-2’-deoxycytidine 
(1.45 g, 4.66 mmol). Characterization of 1H NMR was consistent with that reported for 
this known compound. Yield: 92% 
1H NMR (400 MHz, DMSO-d6) δ ppm 9.94 (s, 1 H) 8.83 (br. s., 1 H) 7.98 (d, J=7.8 Hz, 
1 H) 6.23 (d, J=7.8 Hz, 1 H) 6.08 (s, 1 H) 5.19 (d, J=3.1 Hz, 1 H) 4.20 - 4.28 (m, 3 H) 
2.37 - 2.48 (m, 2 H) 2.06 (s, 3 H) 2.04 (s, 3 H); 13C NMR (101 MHz, DMSO-d6) δ ppm 
170.6, 170.5, 160.3, 147.6, 144.6, 110.0, 94.8, 86.6, 82.4, 74.2, 64.0, 37.0,  21.2, 21.1; 
TLC Rf = 0.22 in DCM: MeOH; 9: 1 
5-iodo-3’, 5’-diacetyl-2’-deoxycytidine (16) 
3’, 5’-diacetyl-2’-deoxycytidine (1.45 g, 4.66 mmol) was added to a round bottom 
flask containing water (7 ml), acetic acid (12 ml) and was stirred until the solid went into 
solution. To this was added chloroform (5 ml), resublimed iodine (I2) (0.473 g, 1.86 
mmol) and iodic acid (HIO3) (0.164 g, 0.932 mmol). The reaction mixture was then 
stirred at 50 °C for 21 hours. The solvent was then removed in vacuo and then subjected 
to flash column chromatography. Eluent was a gradient of acetone: ethyl acetate 50:50 to 
acetone: ethyl acetate 75:25. The fractions corresponding to the product were collected 
and removed in vacuo to yield 5-iodo-3’, 5’-diacetyl-2’-deoxycytidine (1.33 g, 3.04 
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mmol). Characterization of 1H NMR was consistent with that reported for this known 
compound. Yield: 65% 
1H NMR (400 MHz, DMSO-d6) δ ppm 8.09 (s, 1 H) 6.09 (t, J=6.8 Hz, 1 H) 5.14 - 5.22 
(m, 1 H) 4.19 - 4.33 (m, 3 H) 2.43 (d, J=7.4 Hz, 2 H) 2.08 - 2.13 (m, 4 H) 2.06 (s, 3 H); 
TLC Rf value = 0.52 in CH2Cl2: MeOH; 9: 1 
N4-benzoyl-5-iodo-3’, 5’-diacetyl-2’-deoxycytidine (17) 
In a round bottom flask was added 5-iodo-3’,5’-diacetyl-2’-deoxycytidine (1.12 g, 
2.56 mmol) and benzoic anhydride (0.869 g, 3.84 mmol). To this mixture was added 
pyridine (10 ml) and the reaction was heated at 90 °C for five hours under a nitrogen 
atmosphere. On completion, the solvent was removed in vacuo and the crude product was 
extracted in CH2Cl2. The organic layer was dried with sodium sulphate and filtered. The 
solvent was removed in vacuo and the crude product was subjected to flash column 
chromatography: eluent condition was CH2Cl2: methanol; 0 -10% methanol. The 
fractions corresponding to the product were collected and dried via rotary evaporation to 
yield N4-benzoyl-5-iodo-3’, 5’-diacetyl-2’-deoxycytidine (0.64 g, 1.18 mmol). 
Characterization of 1H NMR was consistent with that reported for this known compound. 
Yield: 48% 
1H NMR (400 MHz, CDCl3) δ ppm 8.37 (d, J=7.4 Hz, 2 H) 8.10 (s, 1 H) 7.55 (d, J=7.0 
Hz, 1 H) 7.43 - 7.49 (m, 2 H) 6.30 (d, J=2.7 Hz, 1 H) 5.24 (d, J=6.6 Hz, 1 H) 4.31 - 4.46 
(m, 3 H) 2.23 (s, 3 H) 2.19 (s, 1 H) 2.12 (s, 3 H); 13C NMR (101 MHz, CDCl3) δ ppm 
179.5, 170.0, 169.8, 156.1, 146.9, 144.3, 136.1, 132.7, 129.9, 127.9, 85.6, 82.5, 76.7, 
76.4, 73.8, 63.4, 38.2, 20.8, 20.5; TLC Rf value = 0.41 MeOH: EtOAc; 1: 9  
General procedure for the synthesis of the pyrrolocytidine compounds (18b, 18c, 
18d and 18e) 
To a round bottom flask was added compound 17 (0.050 g, 0.092 mmol) and 3 ml 
of N, N-dimethylformamide. The reaction mixture was then degassed at -78 °C using an 
acetone bath. To this mixture was added copper(I) iodide (0.002 g, 0.009 mmol) and 
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tetrakis(triphenylphosphine)palladium(0) (0.011 g, 0.009 mmol) and the reaction was 
degassed again. Triethylamine (0.051 ml, 0.368 mmol) and the appropriate terminal 
alkyne [1-ethynyl-4-nitrobenzene (0.027 g, 0.184 mmol); (4-((N,N-
(dimethylamino)phenyl)azo)benzene)acetylene (0.276 g, 1.11 mmol); 4-ethynylanisole 
(0.14 ml, 1.11 mmol); 4-ethynylbenzonitrile (0.023 g, 0.184 mmol); 
trimethylsilylacetylene (0.026 ml, 0.184 mmol); phenylacetylene (0.020 ml, 0.184 
mmol)] were added to the reaction mixture and degassed again. The reactions were then 
stirred overnight at a range of 50 °C to 80 °C under a nitrogen atmosphere. The following 
day, 1 ml of anhydrous ethanol and 0.5 ml of triethylamine were added to the reaction 
and it was continued to be heated at 50 °C overnight. The reaction was stopped the 
following day and an extraction was done with CH2Cl2 and 2% aqueous disodium 
ethylenediamine tetraacetate. The organic layer was then collected and dried using 
Na2SO4 and the solvent was dried by rotary evaporation. The crude product was subjected 
to column chromatography using a gradient of CH2Cl2: methanol as the mobile phase 
starting from 0 - 2% MeOH: CH2Cl2. The fractions corresponding to the product were 
collected and removed in vacuo to yield the pyrrolocytidines in various yields.   
Procedure for the synthesis of 18a 
To a round bottom flask was added compound 17 (0.20 g, 0.369 mmol) and 5 ml 
of N, N-dimethylformamide. The reaction mixture was then degassed at -78 °C using an 
acetone bath. To this mixture was added copper(I) iodide (0.014 g, 0.074 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (0.043 g, 0.037 mmol) and the reaction was 
degassed again. Triethylamine (0.21 ml, 1.48 mmol) and (4-((N,N- 
(dimethylamino)phenyl)azo)benzene)acetylene (0.276 g, 1.11 mmol) were added to the 
reaction mixture and degassed again. The reactions were then stirred overnight at 50 °C 
under a nitrogen atmosphere. The following day, 2 ml of anhydrous ethanol and 1 ml of 
triethylamine were added to the reaction and it was continued to be heated at 50 °C 
overnight. The reaction was stopped the following day and an extraction was done with 
CH2Cl2 and 2% aqueous disodium ethylenediamine tetraacetate. The organic layer was 
then collected and dried using Na2SO4 and the solvent was dried by rotary evaporation. 
The crude product was subjected to column chromatography using a gradient of CH2Cl2: 
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methanol as the mobile phase starting from 0 - 2% MeOH: CH2Cl2. The fractions 
corresponding to the product were collected and removed in vacuo to yield the 
pyrrolocytidines in various yields.   
Compounds 18a: 
Yield: (0.122 g, 0.218 mmol) 59%   
1H NMR (400 MHz, CDCl3) δ ppm 11.98 (br. s., 1 H) 8.18 (s, 1 H) 7.98 (d, J=8.6 Hz, 2 
H) 7.83 - 7.90 (m, 4 H) 6.74 (d, J=9.4 Hz, 2 H) 6.51 (s, 1 H) 4.36 (s, 2 H) 3.08 (s, 7 H) 
2.10 (s, 3 H) 2.04 (s, 3 H); 13C NMR (101 MHz, CDCl3) δ ppm 170.5, 170.4, 154.4, 
152.8, 152.4, 143.7, 140.9, 133.9, 131.0, 126.2, 125.1, 122.8, 111.5,  97.0, 88.1, 83.0, 
77.4, 77.0, 76.7, 74.5, 63.8, 40.3, 39.3, 20.9; HRMS (ESI) calculated for [C29H30N6O6]+ : 
558.5851, Found 558.5849. 
Compounds 18b: 
Yield: (0.022 g, 0.051 mmol) 55% 
1H NMR (400 MHz, CDCl3) δ ppm 12.01 (br. S., 1 H) 8.09 (br. s., 1 H) 7.75 (d, J=8.2 
Hz, 2 H) 6.84 (d, J=8.6 Hz, 2 H) 6.25 (s, 1 H) 6.29 (s, 1 H) 5.12 - 5.21 (m, 1 H) 4.26 - 
4.42 (m, 3 H) 3.74 (s, 3 H) 1.89 - 2.15 (m, 7 H); 13C NMR (101 MHz, CDCl3) δ ppm 
169.9, 169.9, 159.3, 141.0, 132.5, 126.5, 122.4, 113.7, 93.9, 87.5, 82.2, 76.7, 76.4, 73.8, 
63.3, 54.7, 38.6, 29.1, 20.3, 20.3 
Compound 18c: 
Yield: (0.016 g, 0.047 mmol) 51% 
1H NMR (400 MHz, CDCl3) δ ppm 8.37 (s, 1 H) 7.13 (d, J=3.9 Hz, 1 H) 6.41 (d, J=7.0 
Hz, 1 H) 6.25 (d, J=3.9 Hz, 1 H) 5.25 (d, J=6.3 Hz, 1 H) 4.33 - 4.53 (m, 4 H) 2.12 - 2.16 
(m, 4 H) 2.08 (s, 3 H); TLC Rf value = 0.14 in DCM: acetone; 8: 2 
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Compound 18d: 
Yield: (0.020 g, 0.049 mmol) 53% 
1H NMR (400 MHz, CHCl3) δ ppm 11.55 (br. s., 1 H) 7.84 (d, J=7.0 Hz, 2 H) 7.45 (t, 
J=7.2 Hz, 2 H) 7.36 (d, J=7.0 Hz, 1 H) 5.26 (d, J=5.9 Hz, 1 H) 4.39 - 4.50 (m, 3 H) 2.16 
(br. s., 1 H) 2.14 (s, 3 H) 2.09 (s, 3 H) 
Compound 18e: 
Yield: (0.009 g, 0.019 mmol) 21% 
1H NMR (400 MHz, DMSO-d6) δ ppm 12.10 (br. s., 1 H) 8.61 (s, 1 H) 8.29 (d, J=9.0 Hz, 
2 H) 8.10 (d, J=9.0 Hz, 2 H) 7.11 (s, 1 H) 6.28 (s, 1 H) 4.26 - 4.42 (m, 4 H) 2.09 (s, 3 H) 
2.06 (s, 3 H); 13C NMR (101 MHz, CDCl3) δ ppm 179.9, 170.3, 170.1, 156.4, 147.3, 
144.6, 136.4, 133.0, 130.3, 128.3, 86.0, 82.9, 77.4, 77.0, 76.7, 74.1, 63.8, 38.5, 21.2, 20.9 
De-acetylation pyrrolocytidine nucleobase (19a) 
 To a round bottom flask was added compound 18a (0.071 g, 0.127 mmol) and 3 
ml of methanol. To that mixture was added potassium carbonate (0.004 g, 0.025 mmol) 
and the mixture was stirred at room temperature for 3 hours. The reaction was monitored 
by TLC and once completed, the solvent was removed in vacuo and the crude product 
was purified by silica gel column chromatography using 10% methanol in 
dichloromethane as the eluent to provide compound 19a.  
Compound 19a: 
Yield: (0.040 g, 0.084 mmol) 67 % 
1H NMR (400 MHz, DMSO-d6) δ ppm 11.89 (br. s., 1 H) 8.77 (s, 1 H) 7.98 (d, J=8.6 Hz, 
2 H) 7.81 (t, J=9.4 Hz, 4 H) 6.79 - 6.89 (m, 3 H) 6.27 (s, 1 H) 5.32 (br. s., 1 H) 3.92 (d, 
J=3.1 Hz, 1 H) 3.06 (s, 6 H); HRMS (ESI) calculated for [C25H26N6O4]+: 474.5117, 
Found 474.5113 
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Chapter 4  
4 Photophysical Quenching Studies 
4.1 Chapter Introduction 
UV-visible spectroscopy refers to absorption spectroscopy in the ultraviolet-
visible spectral region, which causes molecules to undergo electronic transitions and 
concomitant vibrational excitation. The Jablonski diagram shown in Figure 1.7 
represents the possible photophysical processes upon absorption of photons. UV-visible 
spectroscopy is complementary to luminescence, in that absorption measures the 
transition from the ground state to the excited state, while luminescence measures the 
energy dissipation from the excited state to the ground state.[22] 
In the last two decades the detection of DNA hybridization has attracted much 
attention, due to its potential application in the treatment and diagnostics of diseases. One 
methodology for the detection of hybridization is the molecular beacon technology, 
which is one of the most widely used techniques.[38] This is achieved by the labeling of 
DNA probes with fluorescent dyes and non fluorescent quenchers. The technology is 
based on the ability of the quencher to decrease the intensity of the fluorophore when 
they are in close proximity to each other via the FRET mechanism[24] (Figure 4.1).  
 
Figure 4.1: Jablonski diagram showing resonance energy transfer between donor and acceptor fluorophore, 
as well as the spectral overlap for donor emission and absorption spectra of fluorophores. 
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4.2 Results and Discussion 
The photophysical experiments discussed in this chapter for the various 
fluorophores and quenchers were performed in order to determine viable FRET pairs for 
use in molecular probes for the detection of nucleic acids function. In the following 
experiments, the three quenchers used were labeled: 18a, Qb and Qc (Figure 4.2). The 
fluorophores chosen were pyrene (Fa), and a phenylpyrrolocytosine acid moiety (Fb) 
(Figure 4.2). Compound 18a was chosen as a quencher, because azo compounds are 
known to be efficient quenchers and compound Qb and Qc were found to have 
quenching properties. The two fluorophores (compound Fa and Fb) were chosen, 
because they emit in a region of the UV-visible spectrum which overlaps with the 
absorption of the three quenchers, which is a requirement for quenching by FRET 
mechanism. 
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Figure 4.2: Illustration showing structural components of fluorophores and quenchers used in quenching 
studies.  
The fluorophores were chosen based on their excitation and emission 
wavelengths, which are red-shifted from the absorption of natural nucleic acids. For 
optimal performance of fluorescence quenching, delicate matching of the fluorophore and 
quencher is important. The quenchers: 18a, Qb, and Qc absorption are also red-shifted 
from natural nucleic acids. Their λmax absorptions are 445 nm, 400 nm and 397 nm, 
respectively (Figure 4.3).     
The fluorescent emission spectra of the two fluorophores: Fa and Fb were 
observed in the range of 350-650 nm and the fluorophores were excited in the range of 
319 to 334 nm. The wavelength at which the fluorophores were irradiated was based on 
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the observed UV-visible absorbance of a 5 μM solution of the quenchers: 18a, Qb and 
Qc (Figure 4.3).   
For each fluorophore, 1 ml of the solution was added to a cuvette and the sample 
was irradiated in the absence of the quencher. The quencher was then added in microliter 
volume increments and the fluorescent intensity of the solution was measured after each 
addition. The intensity of the fluorescence was measured in the units of counts per 
seconds (1/s).  
The UV-visible spectra for each of the fluorophores was observed before the 
samples were irradiated and after each addition of the quencher. The purpose of this was 
to determine whether the quenching observed was indeed true quenching or direct 
absorption of the light by the quencher upon irradiation. Also, any inner filter effect due 
to the concentration of the fluorophores was constant, because the concentration of the 
fluorophore was not changed during these experiments.  
A linear Stern-Volmer equation in the form of y = mx + b (y-intercept equal to 
one), was generated for each viable FRET pair. The Stern-Volmer rate constant (Ksv) for 
the fluorescent quenching was determined from the slope of the line, using the Stern-
Volmer equation: I0/I = 1 + Ksv [Q].   
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Figure 4.3: UV-visible spectra of a 5 μM solution of 18a (A), Qb (B) and Qc (C). 
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4.2.1 Quenching of 1 μM pyrene (Fa) fluorophore with 1 mM of the 
quencher 18a 
The UV-visible spectrum in Figure 4.4 with the lowest absorbance at 445 nm 
represents the intensity of the pyrene solution at zero concentration of the 1 mM quencher 
18a (Figure 4.4). The emission spectrum of Fa overlaps with the absorbance spectrum of 
18a, which was required for quenching via FRET mechanism as shown in Figure 4.1. 
In this quenching experiment, the sample was irradiated at 334 nm and the UV-
visible spectrum was taken after each addition of the quencher. This was done to observe 
whether there was an increase in the absorbance at the wavelength at which the sample 
was being irradiated with each addition of the quencher. A steady increase at the 
wavelength the sample was being irradiated (with each addition of the quencher) would 
indicate that the quencher was also absorbing the radiation directly. Since this was not the 
case for this fluorophore and quencher, the possibility of them being used as a FRET pair 
was promising. As the concentration of the quencher increased with each addition, there 
was a steady decrease in the fluorescence intensity of the pyrene fluorophore due to 
quenching and an increase in the UV-visible absorbance at approximately 450 nm. The 
increase in the UV-visible absorbance at the λmax of 18a, as well as the lack of absorbance 
of 18a at the irradiated wavelength of 334 nm, was indicative of quenching by FRET 
mechanism. This was very important and crucial to confirm any quenching by FRET 
mechanism, hence the quenching observed was “true” quenching by FRET and not direct 
absorption of the light by the quencher upon irradiation.   
Stern-Volmer analysis allowed explanation of the kinetics of a photophysical 
intermolecular deactivation process. This relationship resulted in a straight line with an 
R2 value of 0.9215 for Fa and 18a which was consistent with the Stern-Volmer plot for 
the mechanism of dynamic quenching. The calculated slope was determined as being 
11,900 L.mol-1, which was the Stern-Volmer rate constant for dynamic quenching. The 
inverse of the Stern-Volmer rate constant   (Ksv-1), was the concentration of the quencher 
at which 50% of the intensity of the fluorophore was quenched. Therefore, 8.43 x 10-5 
mol.L-1of 18a would be required to quench 50% of the pyrene (Fa) fluorophore. A Ksv of 
11,900 L/mol is the product of the bimolecular quenching rate constant (kq) and the 
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fluorescence lifetime (τo) of the excited singlet state of the fluorophore in the absence of 
the quencher. Once the fluorescence lifetime (τo) of the fluorophore is known, the 
quenching rate constant (kq) can be calculated from the slope. In the case of pyrene, the 
fluorescence lifetime (τo) in ethanol at 293 K was reported as 410 x 10-9 seconds,[23] 
hence the bimolecular quenching rate constant kq for the process was, 2.89 x 1010 L.mol-
1.s-1.  This was significant in understanding the interaction between the two molecules, 
the larger the magnitude of the slope, the greater the interaction between the pyrene (Fa) 
fluorophore and the quencher 18a. 
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Figure 4.4: UV-Visible spectra (A), quenching spectra (λex = 334 nm) (B) and Stern-Volmer plot (C) for 1 
μM pyrene and 18a.   
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4.2.2 Quenching of 1 μM pyrene (Fa) fluorophore with 10 mM p-
nitrophenylpC moiety (Qb) 
In a second quenching experiment using the pyrene fluorophore, 10 mM of 
another quencher 6-(4-nitrophenyl)pyrrolocytidine ethyl ester moiety (Qb) was used. 
This sample was irradiated at 319 nm and the UV-visible spectra (Figure 4.5) were taken 
before and after the addition of the quencher with each successive addition. The UV-
visible spectra indicated that the majority of the light absorbed upon irradiation was being 
absorbed directly by the fluorophore and not the quencher. This coupled with the results 
obtained in Figure 4.5, which shows the decrease in the fluorescence intensity of the 
pyrene fluorophore (Fa) as the concentration of the quencher in the solution was 
increased, was an indication of quenching by the mechanism of FRET. Also important 
for the quenching mechanism by FRET is the overlap of the emission spectrum of the 
fluorophore and the absorption spectrum of the quencher, which was the case in this 
experiment.  
A Stern-Volmer linear analysis plot was used to determine the relationship 
between the quenching mechanism of the fluorophore and quencher. A plot of the ratio of 
the fluorescence intensity versus the concentration of the quencher resulted in a straight 
line, which was consistent with the mechanism of dynamic quenching using the Stern-
Volmer plot. The slope was calculated as being 8,100 L.mol-1 from the equation I0/I = 1 + 
Ksv [Q] and had an R2 value of 0.9306. From the slope, the Ksv-1 (which is the 
concentration of the quencher that is required to quench 50% of the fluorophore) was 
determined as being 1.24 x 10-4 mol.L-1. The bimolecular quenching rate constant (kq) 
can also be calculated from the slope once the lifetime (τo) was known. The lifetime of 
pyrene was reported as 410 x 10-9 seconds in ethanol at 293 K.[23] The bimolecular 
quenching rate constant was determined as being 1.97 x 1010 L.mol-1.s-1 for the pyrene 
fluorophore (Fa) and Qb. 
Based on the results obtained from the first two quenchers (18a and Qb) used to 
quench the fluorescence of pyrene, they were able to quench the fluorescence by FRET 
mechanism. The quencher 18a was proven to be more effective at quenching the 
fluorescence of pyrene based on the results obtained. Their Ksv-1 value calculated from 
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the slope of their Stern-Volmer plot resulted in a lower concentration of the quencher 18a 
which was required to quench 50% of the pyrene fluorescence. This was an indication 
that 18a was more effective at quenching the fluorescence of the pyrene, since a lower 
concentration was required to have the same effect.   
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Figure 4.5: UV-visible spectra (A), quenching spectra (λex = 319 nm) (B) and Stern-Volmer analysis plot 
(C) for 1 μM pyrene and Qb. 
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4.2.3 Quenching of 5 μM pyrene (Fa) fluorophore with 10 mM 5-
((4-nitrophenyl)ethynyl) cytosine moiety (Qc) 
In this experiment, a third quencher: 5-((4-nitrophenyl)ethynyl)cytosine ethylester 
moiety (Qc), (Figure 4.2) was used to compare its effectiveness as a quencher compared 
to the first two pyrrolocytosines based quenchers: 18a and Qb. The UV-visible spectra 
(Figure 4.6), which were taken before and after each successive addition of the quencher 
to the pyrene fluorophore did not show any evidence that the quencher absorbed the light 
directly upon irradiation at 334 nm. This was crucial, in order to prove that the observed 
decrease in the fluorescence intensity of the pyrene was due to quenching by FRET 
mechanism and not direct absorption of the light by the quencher at the wavelength of 
excitation.    
A Stern-Volmer plot relating the ratio of the fluorescence intensity to the 
concentration of the quencher was used to better understand the observed quenching. A 
plot of I0/I = 1 + Ksv [Q] resulted in a Stern-Volmer rate constant of 2,100 L.mol-1, with 
an R2 value of 0.9617. The inverse of the Stern-Volmer rate constant (Ksv-1) was 
calculated as being 4.83 x 10-4 mol.L-1, which was the concentration of the Qc quencher 
required to quench 50% of the pyrene fluorophore. The bimolecular quenching rate 
constant (kq) for the quenching process was determined as being 5.05 x 109 L.mol-1.s-1.  
Of the three quenchers used in the quenching of pyrene, the quencher Qc was the 
least efficient at quenching the fluorescence. This was determined from the Stern-Volmer 
rate constants and the Ksv-1 values for each one. The mechanism of quenching for the 
three quenchers with the pyrene fluorophore was due to dynamic quenching. This was 
based on the UV-visible absorbance of each mixture, which is one method for 
distinguishing static from dynamic quenching. This was also supported by the 
bimolecular quenching rate constant kq, since diffusion-controlled values can result in a 
kq value close to 1 x 1010 L.mol-1.s-1.[39]  
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Figure 4.6: UV-visible spectra (A), quenching spectra (λex = 334 nm) (B) and Stern-Volmer analysis plot 
(C) for 5 μM pyrene and Qc. 
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4.2.4 Quenching of 1 μM Fb fluorophore with 1 mM DABCYL 
mimic (18a)   
In this photophysical experiment, another fluorophore was used with the 1 mM 
18a quencher to determine their viability to be used as a FRET pair. The 1 μM solution of 
Fb (Figure 4.2), was analyzed by UV-visible absorbance before the quencher was added 
to the solution and after each successive addition of the quencher. The results of these 
absorbance spectra can be seen in figure 4.7. The fluorophore was irradiated at 320 nm 
and at that wavelength the quencher appeared to have absorbed some of the radiation 
directly (Figure 4.7), this is thought to have been attributed to static and dynamic 
quenching competing with each other. The ability of the quencher to absorb the radiation 
at that wavelength does not appear to be very significant; hence, the observed decrease in 
the fluorescence intensity was probably mainly due to the quenching (Figure 4.7) by 
FRET mechanism. 
 The Stern-Volmer analysis plot (Figure 4.7), based on the equation I0/I = 1 + Ksv 
was used to understand further the mechanism of quenching. Based on the UV-visible 
spectra, it was suspected that the quenching may have been due to a combined static and 
dynamic quenching. In that case, the Stern-Volmer plot was expected to curve upwards 
towards the y-axis.[39] The plot yielded a straight line which was consistent with dynamic 
quenching with a Stern-Volmer rate constant of 16,800 L.mol-1 and an R2 value of 
0.9543. The Ksv-1 for the quencher was calculated as being 5.95 x 10-5 mol.L-1. This 
quencher was slightly more effective at quenching the pyrene fluorophore over the Fb 
fluorophore based on their Ksv-1 value obtained from their slopes. This may be due to 
better overlap of the emission spectrum of pyrene and the absorption spectrum of 18a for 
quenching by FRET mechanism. The emission of the Fb fluorophore was more red-
shifted than the pyrene fluorophore (Fa), so a quencher that absorbs closer to the red 
region in comparison to 18a may be more effective at the quenching of the Fb 
fluorophore.      
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Figure 4.7: UV-visible spectra (A), quenching spectra (λex = 320 nm) (B) and Stern-Volmer analysis plot 
(C) for 1 μM phenylpC acid and 18a. 
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4.2.5 Quenching of 1 μM Fb fluorophore with 10 mM 6-(4-
nitrophenyl)pC ethylester moiety (Qb)  
The quencher Qb ability to be used as a possible FRET pair with another 
fluorophore (Fb) was determined photophysically. In this experiment, a 1 μM solution of 
Fb was used and the UV-visible spectrum was taken. The sample was then irradiated at 
320 nm, after which the quencher Qb was added to the sample and the UV-visible 
spectrum was taken again. The UV-visible spectra obtained from the experiment after 
each successive addition of the quencher indicated that the quencher absorbed the light 
directly upon irradiation (Figure 4.8), or that a ground state complex was being formed 
which perturbed the absorption spectrum of the fluorophore. The sample was irradiated at 
different wavelengths but the result did not change. 
A Stern-Volmer plot was then used to better understand the mechanism of the 
observed quenching. A Stern-Volmer plot of the fluorescence ratio versus the 
concentration of the quencher was expected to produce a straight line for dynamic or 
static quenching, but the line was expected to be second order in relation to the 
concentration of the quencher Qb and curve upwards towards the y-axis in the case of a 
combined static and dynamic quenching happening simultaneously. The Stern-Volmer 
plot yielded a straight line with slope 5600 L.mol-1 and an R2 value of 0.9913. Based on 
the photophysical data obtained, dynamic quenching was eliminated as a possible 
mechanism of quenching due to the perturbation of the UV-visible spectra. The Stern-
Volmer plot indicated that there was not a combined static and dynamic quenching 
happening, because the plot was not second order in relation to the quencher Qb.  
The quenching observed may be due to static quenching, but this was difficult to 
confirm without the fluorescence lifetime (τo) of the fluorophore Fb. For static quenching 
τo/τ = 1.
[39] Another reason for the observed quenching may be due to direct absorption of 
the light upon irradiation by the quencher Qb. The fluorescence lifetime is required to 
confirm the exact mechanism of quenching, but the photophysical data collected has 
eliminated collisional/dynamic quenching. Based on these experimental results, the 
fluorophore Fb and the quencher Qb do not appear to be a good FRET pair.  
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Figure 4.8: UV-Visible spectra (A), quenching spectra (λex = 320 nm) (B) and Stern-Volmer plot (C) for 
1μM phenylpC acid moiety and Qb. 
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4.2.6 Quenching of 1 μM Fb fluorophore with 10 mM 5-((4-
nitrophenyl)ethynyl) cytosine ethylester moiety (Qc) 
In this quenching experiment, a 1 μM solution of the fluorophore Fb and 10 mM 
solution of the quencher Qc were used. The sample was irradiated at 320 nm before and 
after each successive addition of the quencher and the results obtained from the UV-
visible absorbance (Figure 4.9) indicated that it was perturbed. The attempt to irradiate at 
different wavelengths gave the same results. Based on these results, the mechanism of 
dynamic quenching was eliminated as the possible reason for the decrease in the 
fluorescence intensity of the Fb fluorophore.  
 A Stern-Volmer plot which related the ratio of the fluorescence intensity versus 
the concentration of the quencher Qc was plotted to better understand the mechanism of 
the observed quenching. The Stern-Volmer plot was linear with a Ksv value of 1700 
L.mol-1 and an R2 value of 0.9888. A combined quenching of static and dynamic 
occurring simultaneously was eliminated, because the slope was not second order in 
relation to the quencher. Based on these results obtained, the quenching observed may 
have been due to static quenching, but this cannot be confirmed without the fluorescence 
lifetime of the fluorophore. Another possible reason for the observed quenching was 
direct absorption of the light by the quencher Qc at the wavelength the sample was being 
irradiated. Based on these photophysical quenching experiments, the fluorophore Fb and 
Qc are not a good FRET pair. 
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Figure 4.9: UV-visible spectra (A), quenching spectra (λex = 320 nm) (B) and Stern-Volmer plot (C) for 1 
μM phenylpC acid and Qc. 
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4.2.7 Isomerization test for the quencher 18a 
 This experiment was designed to mimic the conditions that the quencher (18a) 
was subjected to upon irradiation to determine if there was any geometric isomerization 
of the azopyrrolocytidine quencher (18a) during the quenching experiments. The trans 
isomer is planar and the pi electrons are delocalized throughout the azopyrrolocytidine 
quencher 18a, making it more thermodynamically stable compared to the cis isomer 
where there is steric clash between the two phenyl rings, causing them to have a skewed 
conformation. Based on previous photoisomerization studies done in the Hudson group 
with azobenzene, the cis form was expected to have an absorbance spectrum with a peak 
that was more red-shifted than the trans form, as well as a decrease in the absorbance at 
the λmax of the trans form (Figure 4.11).[40] The azopyrrolocytidine quencher (18a) was 
expected to be more red-shifted than azobenzene, due to the conjugation between the 
azobenzene moiety and the pyrrolocytosine chromophore, as well as the auxochromic 
NH2 group attach to the chromophore. This bathochromic shift can be observed by the 
difference in absorbance of the λmax of the two trans isomers (Figure 4.10 and Figure 
4.11).   
The isomerization test was performed by the irradiation of a 1 μM sample of 18a 
at 443 nm for 68 seconds in order to be consistent with the integration time per nm with 
the quenching experiments. This was done fifteen times and then the UV-visible 
spectrum of the sample was taken afterwards to observe if there was any change in the 
absorbance. It should be noted that the cumulative irradiation that the 18a sample was 
subjected to during this isomerization experiment was longer than the excitation time of 
the quenching studies. After the sample was irradiated, there was a decrease in the 
absorbance spectrum (Figure 4.10), which may have been due to the formation of the cis 
product. However, there was no new noticeable peak observed at longer wavelength as 
seen in Figure 4.11 for the azobenzene. Although this was not the result obtained, the 
decrease in the absorbance after the first few irradiations may have been due to a small 
percentage of the cis product in equilibrium with the trans isomer. Therefore, the 
equilibrium for this isomerization was to the left (Scheme 4.1) when the 
azopyrrolocytidine was irradiated at 443 nm. Based on the work done by the Hudson 
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group, the azobenzene isomerizes to the cis product when excited under UV light 
between 300 – 400 nm and returns to the trans product when excited thermally or at 
wavelength greater than 400 nm.[40] Scheme 4.2 shows the two proposed mechanisms for 
the trans to cis isomerization of azobenzene.[41]  
  Based on the UV-visible spectra obtained after the sample was irradiated, it was 
reasonable to say that the quenching observed by the addition of 18a was due mainly to 
the trans form of the quencher, since the absorbance of the spectrum is directly 
proportional to the concentration of the solution.    
 
Figure 4.10: Spectra of a 1 μM irradiated sample of 18a. 
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Figure 4.11: UV-visible spectrum of the trans and cis isomer of azobenzene in ethanol at room 
temperature.[40] 
 
 
Scheme 4.1: Trans (left) to cis (right) equilibrium for the isomerization of the azopyrrolocytidine quencher.  
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Scheme 4.2: Proposed mechanisms for the isomerization of the azopyrrolocytidine quencher (18a) from the 
trans-cis isomer. 
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4.2.8 Determination of the quencher 18a molar absorptivity 
 In this experiment, the molar absorptivity of the quencher 18a was determined 
from a plot of the absorbance versus concentration at various wavelengths, according to 
the Beer-Lambert law: A= εbc where: 
A= Absorbance 
ε= molar absorptivity (L.mol-1cm-1) 
b= path length (cm) 
c= concentration (mol/L) 
The molar absorptivity was determined at two wavelengths: 260 and 445 nm, because the 
pyrrolocytosines posses a relatively strong absorbance in the region of 260 nm[1] and at 
approximately 445 nm, the quencher 18a possess another strong absorbance (Figure 4.3). 
The molar absorptivity at 260 and 445 nm was found to be 44,300 and 47,600    L.mol-
1.cm-1, respectively (Figure 4.12) in ethanol. The accepted molar absorptivity for 
DABCYL, SE was found as being 32800 L.mol-1cm-1 at 453 nm in methanol[42] (Figure 
4.13).  
The molar absorptivity for compound Qb was determined by the Hudson group as 
being 9,000 L.mol-1cm-1 at 436 nm in dichloromethane.[1] The molar absorptivity for 
compound Qc was also determined by the Hudson group and was determined to be 2,800 
L.mol-1cm-1 in dichloromethane.[1] Compounds Qb differ from Qc only in the pyrrole 
ring, yet its molar absorptivity was three times that of Qc. The increase in the molar 
absorptivity from the DABCYL, SE quencher was a measure of how strongly 18a 
absorbs light in comparison to the universal DABCYL quencher. This was attributed to 
the intrinsic property of the pyrrolocytosine scaffold which increased the electron 
complexity of the quencher. This has the effect of broadening its absorption spectrum 
which can increase its quenching efficiency; the absorbance (A) of the sample was 
dependant on the path length (b) and the concentration (c) via the Beer-Lambert law. 
Based on the calculated molar absorptivity, the universal DABCYL quencher was made 
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more effective electronically at absorbing light by coupling it to the pyrrolocytosine 
scaffold. This was not surprising, since a similar observation was made by the Crisalli 
group when they increased the electronic complexity of the DABCYL quencher, 
broadening its absorption spectrum, which increased its quenching efficiency and 
versatility.[43]      
The two reference compounds used to compare the values of 18a, Qb and Qc 
were reference compounds 1 and 2 (Figure 4.13). The cytosine-1-acetic acid 
nucleobase (reference compound 2) had a molar absorptivity of 700 L.mol-1cm-1 at 344 
nm in methanol.[1]  
 
 
Figure 4.12: Plots of absorbance versus concentration to determine the molar absorptivity at 260 nm (A) 
and 445 nm (B) for 18a. 
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Figure 4.13: Structural representation of DABCYl, SE and cytosine-1-acetic acid reference compounds. 
4.3 Conclusion 
In conclusion, the Stern-Volmer rate constants (Ksv), Ksv-1 and the bimolecular 
quenching rate constant (kq) were calculated for the FRET pairs (Fa with 18a, Qb and 
Qc) where dynamic quenching was observed. The Ksv and Ksv-1 were also calculated for 
Fb and 18a, but their kq was not determined, because the lifetime of Fb was not known. 
The quenching experiments of Fb using Qb and Qc determined that dynamic quenching 
did not occur. For the three quenchers: 18a, Qb and Qc, the azopyrrolocytidine (18a) had 
the highest Ksv and a lower concentration was required to quench 50% of the 
fluorophores fluorescence (Ksv-1), making it the best quencher of the three.  
Upon subjection to UV-visible irradiation, the azopyrrolocytidine quencher (18a) 
underwent isomerization to the cis product. It was also determined that the equilibrium 
was to the left, based on the UV-visible spectrum of the trans isomer.  
The molar absorptivity was also determined for the azopyrrolocytidine quencher 
(18a) at 260 and 445 nm and was found to be 44,300 and 47,600 L.mol-1.cm-1, 
respectively. This data indicated that the new azopyrrolocytidine quencher (18a) was 
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more efficient at absorbing light than the universal DABCYL, SE quencher based on the 
Beer-Lambert law.  
Overall, the azopyrrolocytidine based on the universal DABCYL quencher was 
found to be a very efficient quencher and the pyrrolocytosine scaffold was found to 
electronically improve the intrinsic property of the DABCYL quencher, hence increasing 
its molar absorptivity.   
4.4 Future Outlook 
Based on the results obtained from the quenching experiments, the quenchers: 
18a, Qb and Qc, were all capable of effectively quenching the pyrene (Fa) fluorophore 
via FRET mechanism. The next step is to synthesize them on a larger scale in order to  
incorporate them into oligomers to be used as molecular beacon technology[14], based on 
the FRET mechanism (Scheme 4.1)[10]. 
          
Scheme 4.3: Illustration of FRET mechanism operation used in molecular beacon technology.[10] 
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4.5 Experimental 
The excitation wavelength, at which the pyrene and 6-phenylpyrrolocytidine were 
excited, was determined experimentally using UV-visible spectroscopy. The fluorescence 
emission spectra were recorded in the range of 350-650 nm for the pyrene and the 6-
phenylpyrrolocytidine fluorophore, by exciting in the range of 319 to 334 nm. This was 
done using a PTI 6000 fluorescence spectrometer. The fluorescence intensity was 
measures in the arbitrary unit of counts per seconds (1/s).   
 The isomerization experiment of the azopyrrolocytidine was done by irradiating 
the quencher at 443 nm and the UV-visible spectra were observed in the range of 800 – 
315 nm. This was performed on a Cary 300 Bio UV-visible spectrometer.  
4.5.1 Preparation of the 5 μM pyrene (Fa) solution 
A 5 μM solution of the pyrene fluorophore was prepared by weighing out 0.0106 
+/- 0.0001 g of the fluorophore. It was then dissolved in 10 ml of anhydrous ethanol to 
produce the stock solution. From that stock solution, 0.01 ml was taken and diluted to 10 
ml in anhydrous ethanol to give the desired concentration of solution.  
4.5.2 Preparation of the 1 μM pyrene (Fa) solution 
A 1 μM solution of the pyrene solution was prepared by taking 1 ml of a 5 μM 
stock solution and diluting it to 5 ml in a volumetric flask.   
4.5.3 Preparation of the 1 μM phenyl pC acid (Fb) solution 
A 5 μM solution of the 6-phenylpyrrolocytidine acid moiety fluorophore was 
prepared by weighing out 0.0011 +/- 0.0001 g of the material and it was dissolved in 10 
ml of anhydrous ethanol. From that stock solution, 2 ml was then taken and diluted to 10 
ml in a volumetric flask; producing the desired concentration of the 1 μM solution of 18a.  
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4.5.4 Preparation of the 1 mM azopyrrolocytidine (18a) solution 
A 1 mM solution of the DABCYL mimic quencher (azopyrrolocytidine) was 
made by weighing out 0.0047 +/- 0.0001 g of the starting material and it was dissolved in 
10 ml of anhydrous ethanol to give the desired concentration of solution.  
4.5.5 Preparation of the 10 mM 6-(4-nitrophenyl) pC moiety (Qb) 
solution 
A 10 mM solution of the 6-(4-nitrophenyl)pyrrolocytidine moiety was prepared 
by weighing out 0.0034 +/- 0.0001 g of the material and it was then dissolved in 1 ml of 
anhydrous ethanol to give the desired concentration of solution. 
4.5.6 Preparation of the 10 mM 5-((4-nitrophenyl)ethynyl)cytosine 
moiety (Qc) solution 
A 10 mM solution of the 5-((4-nitrophenyl)ethynyl)cytosine moiety was prepared 
by weighing out 0.0034 +/- 0.0001 g of the material and it was then dissolved in 1 ml of 
anhydrous ethanol to give the desired concentration of solution. 
4.5.7 Quenching studies 
1 ml of the respective fluorophores ( Fa and Fb) dissolved in anhydrous ethanol 
were added to a cuvette and the excitation wavelength were determined using UV-visible 
absorption. The excitation wavelength for the solution of Fa and Fb were in the range of 
319 – 334 nm. Their emission spectrum was first run in the absence of the quencher and 
then μL volumes of the various quenchers were added to the fluorophore and their 
emission spectrum was run to determine the level of quenching. The UV-visible spectrum 
of each sample was run before and after the addition of the quencher. The total 
concentration of the quencher after each addition was determined and a Stern-Volmer 
analysis plots was used in the analysis of the possible FRET pairs.  
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4.5.8 Isomerization test for the 18a quencher 
1 ml of a 1 μM solution of 18a was added to a quartz cuvette and the sample was 
scanned by UV-visible absorbance from 800 – 315 nm. The sample was then irradiated at 
443 nm for 68 seconds on a pti 6000 fluorometer. After the sample was irradiated, the 
UV-visible absorbance was observed again for any visible changes in the spectrum. The 
radiation and UV-visible absorbance step was repeated fifteen times.    
4.5.9 Determination of the molar absorptivity of 18a 
Using a 100 μL Hamiltonian syringe, 1, 2, 3, 4 and 5 μL volumes of the 1 mM 
quencher 18a, was diluted to 5 ml in a volumetric flask to obtain concentrations of 0.2, 
0.4, 0.6, 0.8 and 1 μM respectively. The UV-visible absorbance of a 1 ml volume for 
each concentration was determined and the absorbance at 260 and 445 nm for each 
concentration was noted. The molar absorptivity was then determined from a plot of 
absorbance versus concentration. 
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Chapter 5  
5 Conclusion and Outlook 
This thesis reports work that was done in the field of nucleic acid chemistry with 
emphasis on the synthesis of modified pyrrolocytidines. The synthesis of these modified 
pyrrolocytidines started with the synthesis towards the 5-phenylpyrrolocytidine, which 
was unsuccessful. The target compound was not attained due to the inability to iodinate at 
the 5-position of the furanouridine. Various methodologies, including Dembinski bicyclic 
halofuranopyrimidine were used with no success. The 5-aromatic substituted 
pyrrolocytidines are still of great interest in our group; their successful synthesis would 
allow determination of the best position for substitution on the pyrrolocytidine scaffold in 
regards to fluorescent properties, as well as allow insight into its ability to form duplexes 
when incorporated into oligomers. It is proposed that for future work, synthesis should 
begin with the unsubstituted pyrrolocytosine nucleobase.  
The successful synthesis of five 6-substituted pyrrolocytidine monomers was 
completed, namely the pyrrolocytidine, 6-(4-methoxyphenyl)pyrrolocytidine and the 6-
phenylpyrrolocytidine fluorophore, as well as the 6-(4-nitrophenyl)pyrrolocytidine and 6-
(4-((N,N-(dimethylamino)phenyl)azo)benzene)pyrrolocytidine quencher. These 
pyrrolocytidine quenchers will be added to our group’s archive of fluorescent quenchers. 
In molecular beacon technology, delicate matching of the fluorophore and quencher is 
required, therefore having quenchers that absorb in the violet to near-infrared region of 
the spectrum (which has broad absorption spectrum) is important.  
The 6-(4-((N,N-(dimethylamino)phenyl)azo)benzene)pyrrolocytidine monomer 
(19a), was used in fluorescence quenching studies to determine if quenching occurred via 
FRET mechanism with a solution of pyrene and 6-phenylpyrrolocytosine fluorophore. 
Two other quenchers (Qb and Qc) were also used to observe their ability to quench the 
selected fluorophores by FRET. Dynamic quenching was observed for the pyrene 
fluorophore with the three quenchers (18a, Qb and Qc), but when paired with the 6-
phenylpyrrolocytosine based fluorophore, the quenching observed was not dynamic 
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quenching. The chromophores, for which FRET was observed, can now be incorporated 
into oligomers after synthesis on a larger scale and subsequent synthesis to the 
phosphoramidite to be used in molecular beacon technology. 
The quencher 18a underwent isomerization to the cis product upon irradiation at 
443 nm for 68 seconds intervals. Based on the decrease in the absorbance of the trans 
form due to isomerization, it was determined that the equilibrium reached between the 
trans-cis isomer was to the left. This was based on the Beer-Lambert law where the 
absorbance is directly proportional to the concentration of the species in solution.  
The molar absorptivity was determined for the quencher 18a at 260 and 445 nm 
and was determined as being 44,300 and 47,600 L.mol-1.cm-1, respectively. The 
calculated molar absorptivity of the azopyrrolocytidine (18a) indicated that the new 
quencher was more effective at absorbing light than the universal quencher DABCYL. 
The azopyrrolocytidine (18a) was more effective at quenching the two fluorophores 
compared to the other two quenchers used. This is significant, because it may be a good 
substitute for quenchers Qb and Qc in molecular beacon technology, due to its improved 
quenching ability and broader absorption spectrum.   
Linear Stern-Volmer analysis plots were used to determine the Stern-Volmer 
constant and concentration of the quencher required to quench 50% of the fluorescence 
for the various FRET pairs. The Stern-Volmer bimolecular quenching rate constant (kq) 
were calculated for the pyrene fluorophore and the quenchers 18a, Qb and Qc; the kq 
values obtained were: 2.89 x 1010, 1.97 x 1010 and 5.05 x 109 L.mol-1.cm-1, respectively 
which confirmed the mechanism of quenching to be dynamic.  
In conclusion, the description of the attempted synthesis towards the 5-
phenylpyrrolocytidine laid the ground work for future endeavors in this area. The 
synthesis and photophysical studies of fluorophores and quenchers that can be used as 
FRET pairs, increases the accessibility to FRET pairs that can be used in molecular 
beacon technology for studies in the field of genetics and medical diagnostics. 
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